Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CR2,Complement receptor type 2,Lifestyle factors,X1050.Time spend outdoors in summer,46285,-0.0410334495664847,0.0172344183777502,-0.0748129095868751,-0.0072539895460943,0.0172743593484376
CR2,Complement receptor type 2,Lifestyle factors,X1060.Time spent outdoors in winter,40396,-0.0294964630565731,0.0194784919091461,-0.0676743071984995,0.00868138108535322,0.129955216667926
CR2,Complement receptor type 2,Physical activities,X1070.Time spent watching television (TV),48666,0.0426028100218853,0.0172851603347597,0.00872389576575636,0.0764817242780143,0.0137160632330622
CR2,Complement receptor type 2,Physical activities,X1080.Time spent using computer,40368,-0.0282191324198851,0.017795645516129,-0.063098597631498,0.00666033279172781,0.112807852235771
CR2,Complement receptor type 2,Physical activities,X1090.Time spent driving,35009,-0.0710455727576527,0.0195785391043086,-0.109419509402097,-0.0326716361132078,0.000285205062674036
CR2,Complement receptor type 2,Lifestyle factors,X1160.Sleep duration,51272,0.00339014821659809,0.01572263996623,-0.0274262261172127,0.0342065225504089,0.829283206980929
CR2,Complement receptor type 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17155,0.00670936030251673,0.0127422906987636,-0.0182655294670599,0.0316842500720933,0.598517996852528
CR2,Complement receptor type 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17155,0.00324714290266283,0.0124027760937951,-0.0210622982411756,0.0275565840465012,0.793472809600175
CR2,Complement receptor type 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17155,0.00959420777965029,0.01414372638828,-0.0181274959413785,0.0373159115006791,0.497567431898563
CR2,Complement receptor type 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17155,-0.0230072427462456,0.0144763632999767,-0.0513809148141999,0.00536642932170874,0.112011767612429
CR2,Complement receptor type 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17155,-0.0151187690714564,0.0147269575515816,-0.0439836058725562,0.0137460677296435,0.304620959317501
CR2,Complement receptor type 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17155,0.0496293878341853,0.0312668928609844,-0.0116537221733442,0.110912497841715,0.112467151009038
CR2,Complement receptor type 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17155,0.0157966142383715,0.0322657631821507,-0.0474442815986439,0.0790375100753868,0.624438671352526
CR2,Complement receptor type 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17155,0.00313542612655191,0.0223791416967311,-0.0407276915990411,0.0469985438521449,0.888578800602568
CR2,Complement receptor type 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17155,0.00398674625920526,0.0163649672321593,-0.028088589515827,0.0360620820342375,0.807532172999432
CR2,Complement receptor type 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17155,-0.00244013052968879,0.0112027251090882,-0.0243974717435016,0.019517210684124,0.827575226383714
CR2,Complement receptor type 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17155,0.0350732024807156,0.016247734628935,0.00322764260800295,0.0669187623534282,0.030891022010968
CR2,Complement receptor type 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17155,0.00111710440654257,0.00907913477701247,-0.0166779997564019,0.018912208569487,0.902076197311394
CR2,Complement receptor type 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17155,0.015801403117611,0.0117443955451032,-0.00721761215079134,0.0388204183860133,0.178500334784523
CR2,Complement receptor type 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17155,-0.0133434155129883,0.0173637239745898,-0.0473763145031842,0.0206894834772077,0.442221516737127
CR2,Complement receptor type 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17155,0.00647366433534452,0.0164077707431953,-0.0256855663213182,0.0386328949920073,0.693180900988889
CR2,Complement receptor type 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17155,0.0162174148263003,0.0218814154795304,-0.0266701595135792,0.0591049891661798,0.458612545409434
CR2,Complement receptor type 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17155,0.00216136953798884,0.0206245399101727,-0.0382627286859496,0.0425854677619273,0.916538900507155
CR2,Complement receptor type 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17155,0.00883783982040755,0.0127430696189644,-0.0161385766327627,0.0338142562735778,0.487979572990121
CR2,Complement receptor type 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17155,-0.00264324914335375,0.0120789578789203,-0.0263180065860375,0.02103150829933,0.826784385993595
CR2,Complement receptor type 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17155,-0.00643395593483368,0.0150815094851478,-0.0359937145257234,0.023125802656056,0.669667168092698
CR2,Complement receptor type 2,Health and medical history,X120040.Fatigue severity over the past week,17167,0.0653925962456621,0.0289032366317648,0.00874225244740311,0.122042940043921,0.0236810692657749
CR2,Complement receptor type 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,17167,0.0556017437249901,0.0285814807503936,-0.000417958545781354,0.111621445995762,0.0517459867230327
CR2,Complement receptor type 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,17167,0.0143310193570542,0.0310747283578156,-0.0465754482242644,0.0752374869383728,0.644675868613676
CR2,Complement receptor type 2,Health and medical history,X120098.Mobility problems today,17176,-0.0176852648808954,0.0338881452121378,-0.0841060294966855,0.0487354997348948,0.601766380723464
CR2,Complement receptor type 2,Health and medical history,X120099.Self-care problems today,17176,0.0485103117760795,0.0524306119897222,-0.0542536877237759,0.151274311275935,0.354859921638795
CR2,Complement receptor type 2,Health and medical history,X120100.Problems doing usual activities,17176,0.00325947207495918,0.0322231417256178,-0.0598978857072518,0.0664168298571701,0.919430073883897
CR2,Complement receptor type 2,Health and medical history,X120101.Pain or discomfort today,17176,-0.00854285091096185,0.0288236409758248,-0.0650371872235784,0.0479514854016547,0.766940829789276
CR2,Complement receptor type 2,Health and medical history,X120102.Anxiety or depression today,17176,0.00881776712074828,0.0350792759551128,-0.0599376137512729,0.0775731479927694,0.801533504494072
CR2,Complement receptor type 2,Health and medical history,X120103.Scale to indicate how health is today,17120,-0.0042852410752116,0.00394184114856123,-0.0120112497263916,0.0034407675759684,0.277000585738086
CR2,Complement receptor type 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17135,-0.0271557414310317,0.0354529883798376,-0.0966435986555134,0.04233211579345,0.443707803204637
CR2,Complement receptor type 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17109,-0.0585767769818644,0.0365294912904204,-0.130174579911088,0.0130210259473595,0.108832291657568
CR2,Complement receptor type 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17146,-0.0363751606215592,0.0287074944539749,-0.0926418497513501,0.0198915285082317,0.205138076750599
CR2,Complement receptor type 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17145,0.042879981891582,0.0293581611089829,-0.0146620138820245,0.100421977665189,0.144148715317485
CR2,Complement receptor type 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17153,0.0304805948450893,0.0381369760943394,-0.0442678782998161,0.105229067989995,0.424162368655589
CR2,Complement receptor type 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,17106,-0.00387492507263435,0.0383786134916553,-0.0790970075162788,0.0713471573710101,0.919578841884907
CR2,Complement receptor type 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,17151,0.0124579420315119,0.0382540766201805,-0.0625200481440419,0.0874359322070657,0.744683225143847
CR2,Complement receptor type 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17134,0.00498150673827379,0.0560645450353357,-0.104905001530984,0.114868015007532,0.929199723037473
CR2,Complement receptor type 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17063,-0.104628579913135,0.0768634122099435,-0.255280867844624,0.0460237080183539,0.17345984183015
CR2,Complement receptor type 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11948,0.0206374607097398,0.0390213374429181,-0.0558443606783797,0.0971192820978592,0.596901098771926
CR2,Complement receptor type 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46395,-0.0637706245942119,0.0383367406183271,-0.138910636206133,0.0113693870177091,0.0962324170451402
CR2,Complement receptor type 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43313,-0.097971057054345,0.0234059462597875,-0.143846711723528,-0.0520954023851616,2.84807089102727e-05
CR2,Complement receptor type 2,Diet and food preferences,X1289.Cooked vegetable intake,49797,-0.0389732375691368,0.0164441275969789,-0.0712037276592154,-0.00674274747905818,0.0177899573902421
CR2,Complement receptor type 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48441,-0.0314100492203423,0.017441337233833,-0.065595070198655,0.00277497175797047,0.0717253592922382
CR2,Complement receptor type 2,Diet and food preferences,X1309.Fresh fruit intake,49698,0.0911888854708403,0.0171947296518891,0.0574872153531377,0.124890555588543,1.14210307823235e-07
CR2,Complement receptor type 2,Diet and food preferences,X1319.Dried fruit intake,46924,0.0542270973167992,0.0176913460578174,0.0195520590434772,0.0889021355901213,0.00217665154993099
CR2,Complement receptor type 2,Health and medical history,X134.Number of self-reported cancers,51710,-0.0564490925626343,0.0304171894209105,-0.116066783827619,0.00316859870235024,0.0634836680599902
CR2,Complement receptor type 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51711,0.115626406049357,0.0164208944160577,0.083441452993884,0.14781135910483,1.92656971091625e-12
CR2,Complement receptor type 2,Health and medical history,"X136.Number of operations, self-reported",51711,0.0773620838489085,0.0161238028788046,0.0457594302064514,0.108964737491366,1.60700236558494e-06
CR2,Complement receptor type 2,Health and medical history,X137.Number of treatments or medications taken,51711,0.0825295757172489,0.0161013868321578,0.0509708575262195,0.114088293908278,2.97627339510157e-07
CR2,Complement receptor type 2,Diet and food preferences,X1438.Bread intake,50216,0.0147861919634739,0.00244855312898365,0.00998702783066591,0.0195853560962818,1.5640348632592e-09
CR2,Complement receptor type 2,Diet and food preferences,X1458.Cereal intake,49099,0.134134062526486,0.0163464836005701,0.102094954669369,0.166173170383604,2.3479471618382e-16
CR2,Complement receptor type 2,Diet and food preferences,X1488.Tea intake,49909,0.00545360490931065,0.00234380518433272,0.000859746748018524,0.0100474630706028,0.0199790080788217
CR2,Complement receptor type 2,Diet and food preferences,X1498.Coffee intake,47636,-0.0504971825701254,0.0164414171255138,-0.0827223601361324,-0.0182720050041184,0.0021322041049148
CR2,Complement receptor type 2,Diet and food preferences,X1528.Water intake,47790,-0.0153692645826818,0.0166507530295066,-0.0480047405205148,0.0172662113551511,0.35599247703287
CR2,Complement receptor type 2,Lifestyle factors,X1568.Average weekly red wine intake,35168,-0.0771278225993754,0.0191451076886876,-0.114652233669203,-0.0396034115295478,5.62298530011613e-05
CR2,Complement receptor type 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35157,-0.100693178220277,0.0196801152835831,-0.1392662041761,-0.0621201522644538,3.12903581891929e-07
CR2,Complement receptor type 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,35258,-0.121611106853292,0.0218866189838056,-0.164508880061551,-0.0787133336450334,2.77360982753431e-08
CR2,Complement receptor type 2,Lifestyle factors,X1598.Average weekly spirits intake,35115,-0.0517575522567938,0.0210964725533666,-0.0931066384613924,-0.0104084660521952,0.0141571094162686
CR2,Complement receptor type 2,Lifestyle factors,X1608.Average weekly fortified wine intake,35231,0.0490296362188802,0.0345926038534011,-0.0187718673337859,0.116831139771546,0.15639108266746
CR2,Complement receptor type 2,Lifestyle factors,X1737.Childhood sunburn occasions,38805,-0.0460323901148908,0.0194531450931351,-0.0841605544974356,-0.00790422573234605,0.0179707336482247
CR2,Complement receptor type 2,Health and medical history,X1807.Father's age at death,38093,0.00444924210465064,0.00272869356739443,-0.000898997287442454,0.00979748149674373,0.102995836174192
CR2,Complement receptor type 2,Health and medical history,X1845.Mother's age,19656,-0.00988130317255886,0.00603878416362104,-0.0217173201332561,0.00195471378813838,0.101791429437826
CR2,Complement receptor type 2,Health and medical history,X1873.Number of full brothers,50783,-0.0128379333557441,0.0158165161001875,-0.0438383049121116,0.0181624382006234,0.4169796751719
CR2,Complement receptor type 2,Health and medical history,X1883.Number of full sisters,50791,-0.0257642952472786,0.0158713461929065,-0.0568721337853753,0.0053435432908182,0.104526933958372
CR2,Complement receptor type 2,Physical measures,X20015.Sitting height,51306,0.0186668972921446,0.00308141367454875,0.0126273264900291,0.0247064680942602,1.38866594644189e-09
CR2,Complement receptor type 2,Cognitive function,X20016.Fluid intelligence score,16562,-0.0590034624625335,0.0260446557602499,-0.110050987752623,-0.00795593717244365,0.0234965499915356
CR2,Complement receptor type 2,Cognitive function,X20018.Prospective memory result,17245,0.0381217429987709,0.0342186506431386,-0.0289468122617807,0.105190298259323,0.265267570099586
CR2,Complement receptor type 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16347,0.0163569017788418,0.00427476937365667,0.00797835380647468,0.0247354497512088,0.000130524612204173
CR2,Complement receptor type 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16321,0.0140188758052437,0.00427848384049448,0.00563304747787455,0.0224047041326129,0.00105284964123923
CR2,Complement receptor type 2,Cognitive function,X20023.Mean time to correctly identify matches,51083,0.00636042052982251,0.002480210426881,0.00149920809313575,0.0112216329665093,0.0103362399908064
CR2,Complement receptor type 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44974,0.000812078020066861,0.00528111961533622,-0.00953891642599213,0.0111630724661258,0.877791740791813
CR2,Complement receptor type 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44095,-0.00228691234537667,0.0116359235904099,-0.0250933225825801,0.0205194978918268,0.844189245994888
CR2,Complement receptor type 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44022,-0.00284170800299877,0.015582601761098,-0.0333836074547508,0.0277001914487533,0.855297794225922
CR2,Complement receptor type 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44063,-0.00704822479565723,0.0131991518284054,-0.0329185623793319,0.0188221127880174,0.59335063838529
CR2,Complement receptor type 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44088,-0.000994087800582094,0.0094113923452864,-0.0194404167973434,0.0174522411961792,0.915879569684675
CR2,Complement receptor type 2,Health and medical history,X20107#2.Illnesses of father_Stroke,44428,0.0131000858003078,0.00680733664349928,-0.000242294020950782,0.0264424656215664,0.0543099778020872
CR2,Complement receptor type 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44306,-0.00836469119654036,0.00858987865365722,-0.0252008533577085,0.0084714709646278,0.330168839469898
CR2,Complement receptor type 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44110,-0.0111155147028867,0.0107117041432031,-0.0321104548235647,0.00987942541779127,0.299416334437159
CR2,Complement receptor type 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44390,-0.00491301128250594,0.00786232492808802,-0.0203231681415585,0.0104971455765466,0.532052892229045
CR2,Complement receptor type 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44537,0.0113850292329885,0.00591654348683856,-0.000211396001215051,0.0229814544671921,0.0543270704860767
CR2,Complement receptor type 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44260,0.0300936461699678,0.00819813463452601,0.0140253022862968,0.0461619900536387,0.000242084306616889
CR2,Complement receptor type 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47164,0.0222712819048078,0.00604585145129883,0.0104214130602621,0.0341211507493535,0.0002301028972389
CR2,Complement receptor type 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46873,-0.012240503021241,0.00867518843311837,-0.029243872350153,0.00476286630767102,0.15825763804593
CR2,Complement receptor type 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46724,-0.0114612829633949,0.0188909404358922,-0.0484875262177437,0.0255649602909538,0.544047721499714
CR2,Complement receptor type 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46798,0.0138198748081194,0.00973564120527268,-0.00526198195421511,0.0329017315704538,0.155756006112261
CR2,Complement receptor type 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,47044,-0.0128607828398622,0.00688737419318981,-0.0263600362585143,0.000638470578789789,0.0618661441003182
CR2,Complement receptor type 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46825,-0.00548304140206197,0.0121924629905802,-0.0293802688635992,0.0184141860594753,0.652923483334041
CR2,Complement receptor type 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46789,-0.0257233413508183,0.010905031086133,-0.0470972022796389,-0.00434948042199773,0.0183357122334341
CR2,Complement receptor type 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46826,-0.0154763373103637,0.00888476519207154,-0.032890477086824,0.00193780246609649,0.0815332049153333
CR2,Complement receptor type 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46877,-0.00726893200980395,0.0102062136732271,-0.0272731108093292,0.0127352467897213,0.476340440422661
CR2,Complement receptor type 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47244,0.0183558742654467,0.00522570450687309,0.00811349343197546,0.028598255098918,0.000444138588532272
CR2,Complement receptor type 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46942,0.0204238804370372,0.00807555385089541,0.00459579488928217,0.0362519659847922,0.0114388025169198
CR2,Complement receptor type 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40445,0.0082726881543902,0.00848740328662996,-0.00836262228740452,0.0249079985961849,0.329713979083992
CR2,Complement receptor type 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40152,0.00486248949067757,0.0338062761323351,-0.0613978117286993,0.0711227907100545,0.8856323327584
CR2,Complement receptor type 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40142,0.0115941219957213,0.0342163663210368,-0.0554699559935109,0.0786581999849534,0.734726569307012
CR2,Complement receptor type 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40260,-0.0107845615292212,0.0100124932895479,-0.0304090483767351,0.00883992531829266,0.28143736445084
CR2,Complement receptor type 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40173,0.00477021681381268,0.0197572567517702,-0.0339540064196568,0.0434944400472822,0.809214376160073
CR2,Complement receptor type 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40220,-0.0169863743249473,0.0143570616163152,-0.0451262150929251,0.0111534664430305,0.236761754821789
CR2,Complement receptor type 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40174,-0.0456563434976737,0.0169670180039511,-0.078911698785418,-0.0124009882099295,0.00712916241937011
CR2,Complement receptor type 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40176,-0.00396628024444414,0.0164332686925891,-0.0361754868819189,0.0282429263930306,0.809279866343449
CR2,Complement receptor type 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40201,-0.012195099230134,0.0125221088370036,-0.0367384325506611,0.012348234090393,0.330119295403456
CR2,Complement receptor type 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40220,0.00123724736803255,0.0154086250501918,-0.0289636577303435,0.0314381524664086,0.936002424369731
CR2,Complement receptor type 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40581,0.0142067455547392,0.00633570126162637,0.00178877108195148,0.0266247200275269,0.0249453041920921
CR2,Complement receptor type 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40362,0.0304848434921491,0.00898935055435972,0.012865716405604,0.0481039705786941,0.000696495507271203
CR2,Complement receptor type 2,Mental health,X20127.Neuroticism score,41132,0.0232561702629679,0.01654638314231,-0.00917474069595958,0.0556870812218954,0.159876098773271
CR2,Complement receptor type 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16562,-0.00616979593530267,0.0263911859670212,-0.0578965204306643,0.045556928560059,0.815156774029978
CR2,Complement receptor type 2,Lifestyle factors,X20161.Pack years of smoking,15722,0.00283003060032461,0.00458409226534382,-0.00615479023974928,0.0118148514403985,0.537006910096282
CR2,Complement receptor type 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15722,0.00251088698504364,0.00452285325124869,-0.00635390538740378,0.0113756793574911,0.578796189833998
CR2,Complement receptor type 2,Cognitive function,X20191.Fluid intelligence score,12757,-0.0261000929483618,0.0304508260816249,-0.0857837120683466,0.033583526171623,0.391393234845527
CR2,Complement receptor type 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12758,-0.0349510717549329,0.0310532447141689,-0.0958154313947039,0.025913287884838,0.260389638696303
CR2,Complement receptor type 2,Cognitive function,X20240.Maximum digits remembered correctly,11452,-0.0294141491378337,0.0327385339553408,-0.0935816756903017,0.0347533774146343,0.368961143614394
CR2,Complement receptor type 2,Physical measures,X20255.Spirometry QC measure,38455,0.0190049277772984,0.0212979713193226,-0.0227390960085738,0.0607489515631707,0.372218921086571
CR2,Complement receptor type 2,Eye measures,X20261.avMSE,11295,-0.00296896027927003,0.0050357042072308,-0.0128389405254424,0.00690101996690234,0.55548276672232
CR2,Complement receptor type 2,Eye measures,X20262.Myopia diagnosis,11295,0.0465712284874762,0.0397053704281181,-0.0312512975516352,0.124393754526588,0.240852601758036
CR2,Complement receptor type 2,NMR metabolomics,X20280.Glucose-lactate,29521,0.0166864669443139,0.0031305818563581,0.010550526505852,0.0228224073827758,9.88522268092875e-08
CR2,Complement receptor type 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,29584,0.0140787040890869,0.00314032351696959,0.00792366999582648,0.0202337381823473,7.38074091742738e-06
CR2,Complement receptor type 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16164,-0.0347779073250679,0.0165882452908723,-0.0672908680951776,-0.00226494655495813,0.0360498985070529
CR2,Complement receptor type 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16161,0.0180464366887892,0.032713329010998,-0.0460716881727669,0.0821645615503453,0.581193109954441
CR2,Complement receptor type 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16160,-0.0276052120623566,0.0400565708950039,-0.106116091016564,0.0509056668918509,0.490735227198712
CR2,Complement receptor type 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16160,-0.0154796757187168,0.0157350764825771,-0.0463204256245678,0.0153610741871343,0.325243993860694
CR2,Complement receptor type 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16160,-0.0598776259352836,0.0273954901932734,-0.113572786714099,-0.00618246515646777,0.028853738563102
CR2,Complement receptor type 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16170,-0.0159859648979831,0.0353028359670242,-0.0851795233933506,0.0532075935973844,0.650681693450678
CR2,Complement receptor type 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16170,-0.00685261026845167,0.022803735605942,-0.0515479320560979,0.0378427115191946,0.763796729320423
CR2,Complement receptor type 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16170,-0.00193654389168423,0.0254126388025766,-0.0517453159447343,0.0478722281613659,0.939257770135742
CR2,Complement receptor type 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16170,-0.00276060022690434,0.0395656521767567,-0.0803092784933474,0.0747880780395387,0.944375483293034
CR2,Complement receptor type 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16170,0.0352841579840899,0.0461068872181021,-0.0550853409633903,0.12565365693157,0.444122732443559
CR2,Complement receptor type 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16170,0.0128284206948232,0.0266541080481893,-0.0394136310796279,0.0650704724692742,0.630315187783649
CR2,Complement receptor type 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16170,0.070085969741628,0.0455942947332776,-0.0192788479355961,0.159450787418852,0.124272407732254
CR2,Complement receptor type 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16170,0.0164897426591654,0.0339067422973607,-0.0499674722436615,0.0829469575619924,0.626742387049085
CR2,Complement receptor type 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16172,-0.0162018918728506,0.0455755530267363,-0.105529975805254,0.0731261920595525,0.72222325552114
CR2,Complement receptor type 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16172,-0.0235917058869221,0.0211735075424365,-0.0650917806700976,0.0179083688962535,0.265206245671037
CR2,Complement receptor type 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16172,-0.0410027808210702,0.0316910541259054,-0.103117246907845,0.0211116852657043,0.195743248944143
CR2,Complement receptor type 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16174,0.0058348222189577,0.0528484352525658,-0.0977481108760712,0.109417755313987,0.912088197566836
CR2,Complement receptor type 2,Diet and food preferences,X20600.Liking for adding salt to foods,18690,-0.0521900318228255,0.0251453958252447,-0.101475007640305,-0.00290505600534595,0.03795106990122
CR2,Complement receptor type 2,Diet and food preferences,X20601.Liking for aniseed,18690,-0.0496504174610797,0.0251579798156071,-0.0989600578996697,-0.000340777022489747,0.0484481723306949
CR2,Complement receptor type 2,Diet and food preferences,X20602.Liking for apple juice,18690,0.0209950874319016,0.0252698695218193,-0.0285338568308641,0.0705240316946674,0.406077576896673
CR2,Complement receptor type 2,Diet and food preferences,X20603.Liking for apples,18690,0.0756591863759466,0.0259346974960703,0.0248271792836488,0.126491193468244,0.00353501448410679
CR2,Complement receptor type 2,Diet and food preferences,X20604.Liking for asparagus,18690,-0.0110135011869865,0.0257426681675032,-0.0614691307952928,0.0394421284213199,0.66877939170381
CR2,Complement receptor type 2,Diet and food preferences,X20605.Liking for aubergine,18690,-0.0263917300731359,0.0252717325073453,-0.0759243257875327,0.023140865641261,0.296351720832393
CR2,Complement receptor type 2,Diet and food preferences,X20606.Liking for avocados,18690,-0.0527293212023979,0.0255609013577283,-0.102828687863545,-0.00262995454125043,0.0391369036794272
CR2,Complement receptor type 2,Diet and food preferences,X20607.Liking for bacon,18690,-0.0839800423288236,0.0257120943956121,-0.134375747344223,-0.0335843373134239,0.00109209812865981
CR2,Complement receptor type 2,Diet and food preferences,X20608.Liking for baked or steamed fish,18690,-0.00758953899360873,0.0257394922321054,-0.0580389437685353,0.0428598657813179,0.768104336614606
CR2,Complement receptor type 2,Diet and food preferences,X20609.Liking for bananas,18690,0.0297667601659437,0.0262165154348962,-0.0216176100864528,0.0811511304183403,0.256213894353263
CR2,Complement receptor type 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18690,-0.0588894905274187,0.0255344075092991,-0.108936929245645,-0.00884205180919247,0.0211058975659748
CR2,Complement receptor type 2,Diet and food preferences,X20611.Liking for beef steak,18690,-0.0855895962338403,0.0256626690258183,-0.135888427524444,-0.0352907649432364,0.000854105974575457
CR2,Complement receptor type 2,Diet and food preferences,X20612.Liking for beetroot,18690,0.00304427028073031,0.025708600653297,-0.0473445869997319,0.0534331275611925,0.905740536395209
CR2,Complement receptor type 2,Diet and food preferences,X20613.Liking for bell pepper,18690,-0.0421611160471431,0.025507871376442,-0.0921565439449694,0.00783431185068317,0.098374773514329
CR2,Complement receptor type 2,Diet and food preferences,X20614.Liking for bicycling,18690,-0.0446482558638525,0.025321755972292,-0.0942788975695449,0.0049823858418399,0.0778768920555969
CR2,Complement receptor type 2,Diet and food preferences,X20615.Liking for biscuits,18690,0.0126204067601916,0.0254410624330062,-0.0372440756085005,0.0624848891288837,0.619854777223847
CR2,Complement receptor type 2,Diet and food preferences,X20616.Liking for bitter foods,18690,-0.0597306243906968,0.0254565866507093,-0.109625534226087,-0.00983571455530653,0.0189675715743042
CR2,Complement receptor type 2,Diet and food preferences,X20617.Liking for bitter or ale,18690,-0.149621494749112,0.0259749903233597,-0.200532475782897,-0.0987105137153267,8.53286398466041e-09
CR2,Complement receptor type 2,Diet and food preferences,X20618.Liking for black olives,18690,-0.0748427499744397,0.0254691780882497,-0.124762339027409,-0.0249231609214702,0.00330142566862504
CR2,Complement receptor type 2,Diet and food preferences,X20619.Liking for black pepper,18690,-0.0641186577472684,0.025625476904818,-0.114344592480712,-0.0138927230138252,0.0123528222083251
CR2,Complement receptor type 2,Diet and food preferences,X20620.Liking for blue cheese,18690,-0.0965107749689059,0.0253944227433175,-0.146283843545808,-0.0467377063920035,0.000144879787827105
CR2,Complement receptor type 2,Diet and food preferences,X20621.Liking for bolognese sauce,18690,-0.0537134684685507,0.0256163342896562,-0.103921483676277,-0.00350545326082458,0.0360207677977498
CR2,Complement receptor type 2,Diet and food preferences,X20622.Liking for broad beans,18690,0.0101968118251499,0.0254160347275716,-0.0396186162408905,0.0600122398911902,0.6882804073949
CR2,Complement receptor type 2,Diet and food preferences,X20623.Liking for broccoli,18690,0.0255444554019238,0.0261361681533103,-0.0256824341785645,0.076771344982412,0.32840343293242
CR2,Complement receptor type 2,Diet and food preferences,X20624.Liking for brown rice,18690,0.0165589381370455,0.0255195930391047,-0.0334594642195997,0.0665773404936906,0.51642938141417
CR2,Complement receptor type 2,Diet and food preferences,X20625.Liking for brussel sprouts,18690,0.0219241319308095,0.0255517380381893,-0.0281572746240416,0.0720055384856605,0.390887473276352
CR2,Complement receptor type 2,Diet and food preferences,X20626.Liking for burgers (meat),18690,-0.059667135136585,0.0254021982596817,-0.109455443725561,-0.00987882654760895,0.0188395070877935
CR2,Complement receptor type 2,Diet and food preferences,X20627.Liking for burn of spicy foods,18690,-0.117846765977945,0.0252608161262363,-0.167357965585368,-0.0683355663705218,3.10454997906785e-06
CR2,Complement receptor type 2,Diet and food preferences,X20628.Liking for butter on bread,18690,-0.0302308274786469,0.0256558405253755,-0.080516274908383,0.0200546199510891,0.238683495775685
CR2,Complement receptor type 2,Diet and food preferences,X20629.Liking for butternut squash,18690,0.0216187667179679,0.0256022205895166,-0.0285615856374847,0.0717991190734205,0.39845125307632
CR2,Complement receptor type 2,Diet and food preferences,X20630.Liking for cabbage,18690,0.0198877946627281,0.0256951451866561,-0.0304746899031178,0.070250279228574,0.438946294286803
CR2,Complement receptor type 2,Diet and food preferences,X20631.Liking for cake,18690,0.0356410131806917,0.0255662101488154,-0.0144687587109865,0.0857507850723698,0.163313927381323
CR2,Complement receptor type 2,Diet and food preferences,X20632.Liking for cake icing,18690,-0.0182345583492859,0.025239726180881,-0.0677044216638128,0.0312353049652409,0.470024028489804
CR2,Complement receptor type 2,Diet and food preferences,X20633.Liking for capers,18690,-0.0754285181489343,0.0251707274679633,-0.124763143986142,-0.0260938923117262,0.00273299219174681
CR2,Complement receptor type 2,Diet and food preferences,X20634.Liking for cauliflower,18690,-0.0041172987629067,0.0258553478434707,-0.0547937805361092,0.0465591830102958,0.873478674234999
CR2,Complement receptor type 2,Diet and food preferences,X20635.Liking for cereal or granola bar,18690,-0.00338731741137563,0.0252047695826143,-0.0527886657932998,0.0460140309705485,0.893094118378542
CR2,Complement receptor type 2,Diet and food preferences,X20636.Liking for cheesecake,18690,-0.0212908672050273,0.0253624994946871,-0.0710013662146139,0.0284196318045593,0.401220575178179
CR2,Complement receptor type 2,Diet and food preferences,X20637.Liking for cherries,18690,0.0121375680398108,0.0267974221464751,-0.0403853793672804,0.0646605154469021,0.650598725164752
CR2,Complement receptor type 2,Diet and food preferences,X20638.Liking for chicken,18690,0.0192535777251983,0.0266368407289547,-0.0329546301035529,0.0714617855539494,0.469800998577358
CR2,Complement receptor type 2,Diet and food preferences,X20639.Liking for chilli pepper,18690,-0.0945018952278262,0.0252676567501209,-0.144026502458063,-0.0449772879975893,0.000184545459126108
CR2,Complement receptor type 2,Diet and food preferences,X20640.Liking for chips or french fries,18690,-0.0312902468520961,0.0254058809705776,-0.0810857735544282,0.018505279850236,0.218108703540572
CR2,Complement receptor type 2,Diet and food preferences,X20641.Liking for cigarette smoking,18690,0.0495044174644276,0.041400709179465,-0.0316409725273238,0.130649807456179,0.231813852935468
CR2,Complement receptor type 2,Diet and food preferences,X20642.Liking for cod,18690,0.0141123207009312,0.0260666101581101,-0.0369782352089645,0.065202876610827,0.58824212328672
CR2,Complement receptor type 2,Diet and food preferences,X20643.Liking for coffee with sugar,18690,0.00486581708032722,0.0276494189927082,-0.0493270441453809,0.0590586783060354,0.860309508806085
CR2,Complement receptor type 2,Diet and food preferences,X20644.Liking for coffee without sugar,18690,-0.0565270659402152,0.0257052370808706,-0.106909330618722,-0.00614480126170878,0.0278866861881481
CR2,Complement receptor type 2,Diet and food preferences,X20645.Liking for coriander,18690,-0.107713955513327,0.0253722424080687,-0.157443550633142,-0.0579843603935124,2.19310784719717e-05
CR2,Complement receptor type 2,Diet and food preferences,X20646.Liking for corn flakes,18690,0.0545024372743932,0.0252193851705466,0.00507244234012188,0.103932432208664,0.0306977672736876
CR2,Complement receptor type 2,Diet and food preferences,X20647.Liking for cream,18690,0.0262515741947893,0.0253305366560292,-0.0233962776510279,0.0758994260406065,0.300047294793095
CR2,Complement receptor type 2,Diet and food preferences,X20648.Liking for croissant,18690,-0.00511903952483617,0.0253436456168067,-0.0547925849337774,0.0445545058841051,0.83993055109797
CR2,Complement receptor type 2,Diet and food preferences,X20649.Liking for cucumber,18690,0.0248893612401481,0.0257195801244583,-0.0255210158037901,0.0752997382840863,0.33319658635851
CR2,Complement receptor type 2,Diet and food preferences,X20650.Liking for curry,18690,-0.0980481456063547,0.0255592921010965,-0.148144358124504,-0.0479519330882056,0.00012541182999288
CR2,Complement receptor type 2,Diet and food preferences,X20651.Liking for dairy products,18690,0.0476178572575808,0.0258318263275009,-0.00301252234432095,0.0982482368594826,0.0652894733439836
CR2,Complement receptor type 2,Diet and food preferences,X20652.Liking for dark chocolate,18690,-0.0086811840634607,0.0255959447835205,-0.0588492358391609,0.0414868677122395,0.734491149071508
CR2,Complement receptor type 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18690,0.00284074042824085,0.0261261434699585,-0.0483665007728779,0.0540479816293596,0.913416453440726
CR2,Complement receptor type 2,Diet and food preferences,X20654.Liking for dried fruit,18690,0.0300372226623589,0.0254552747232791,-0.0198551157952682,0.079929561119986,0.23801527545341
CR2,Complement receptor type 2,Diet and food preferences,X20655.Liking for eggs,18690,-0.0297187244840187,0.026184058619693,-0.0810394793786171,0.0216020304105796,0.256392804780365
CR2,Complement receptor type 2,Diet and food preferences,X20656.Liking for exercising alone,18690,-0.04286804763918,0.0252287853371965,-0.0923164669000852,0.00658037162172508,0.0893034277232376
CR2,Complement receptor type 2,Diet and food preferences,X20657.Liking for exercising with others,18690,0.00857739615924801,0.0252277500334867,-0.0408689939063859,0.058023786224882,0.733861513179941
CR2,Complement receptor type 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18690,-0.0346781810860061,0.0257289686180714,-0.0851069595774261,0.0157505974054138,0.177730606821904
CR2,Complement receptor type 2,Diet and food preferences,X20659.Liking for fatty foods,18690,-0.0264683396597179,0.0252174225659756,-0.0758944878890301,0.0229578085695943,0.293913220721866
CR2,Complement receptor type 2,Diet and food preferences,X20660.Liking for fresh tomatoes,18690,-0.0205118529090973,0.0271408062131439,-0.0737078330868593,0.0326841272686648,0.449804468726035
CR2,Complement receptor type 2,Diet and food preferences,X20661.Liking for fried chicken,18690,-0.0195318099681003,0.0253086078761269,-0.069136681405309,0.0300730614691084,0.440274811690752
CR2,Complement receptor type 2,Diet and food preferences,X20662.Liking for fried or battered fish,18690,-0.0463175605077627,0.0253141667011804,-0.0959333272420762,0.00329820622655085,0.0673093934431352
CR2,Complement receptor type 2,Diet and food preferences,X20663.Liking for fruit,18690,0.0698006096471223,0.0282429179830958,0.0144444904002545,0.12515672889399,0.0134659587904021
CR2,Complement receptor type 2,Diet and food preferences,X20664.Liking for garlic,18690,-0.0623268911337538,0.0257200207521293,-0.112738131807927,-0.0119156504595803,0.0153903810079725
CR2,Complement receptor type 2,Diet and food preferences,X20665.Liking for gherkins,18690,-0.0822357907895728,0.0252588844230639,-0.131743204258778,-0.0327283773203675,0.0011330782133048
CR2,Complement receptor type 2,Diet and food preferences,X20666.Liking for globe artichoke,18690,-0.0270681077549631,0.0253753308540546,-0.07680375622891,0.0226675407189839,0.286116808991972
CR2,Complement receptor type 2,Diet and food preferences,X20667.Liking for goat's cheese,18690,-0.0595194451913017,0.0252249147645912,-0.108960278129901,-0.0100786122527029,0.0183073552975388
CR2,Complement receptor type 2,Diet and food preferences,X20668.Liking for going to a cafe,18690,0.0409677612974401,0.02559709047407,-0.00920253603173712,0.0911380586266174,0.109507937341583
CR2,Complement receptor type 2,Diet and food preferences,X20669.Liking for going to the gym,18690,-0.0542177249811864,0.0252938607288359,-0.103793692009705,-0.00464175795266807,0.0320847930878616
CR2,Complement receptor type 2,Diet and food preferences,X20670.Liking for going to the pub,18690,-0.182183176249941,0.0253331615495521,-0.231836172887063,-0.132530179612819,6.65121799376094e-13
CR2,Complement receptor type 2,Diet and food preferences,X20671.Liking for grapefruit,18690,-0.0424659112503833,0.0254314185503161,-0.0923114916090029,0.00737966910823639,0.0949715937083914
CR2,Complement receptor type 2,Diet and food preferences,X20672.Liking for green olives,18690,-0.0455920275970286,0.0254770715023935,-0.0955270877417197,0.00434303254766261,0.0735454286830579
CR2,Complement receptor type 2,Diet and food preferences,X20673.Liking for haddock,18690,-0.023417647328277,0.025948331416025,-0.074276376903686,0.027441082247132,0.366817735648453
CR2,Complement receptor type 2,Diet and food preferences,X20674.Liking for ham,18690,-0.0437587252929831,0.0256231015453384,-0.0939800043218463,0.00646255373588017,0.0876930386283311
CR2,Complement receptor type 2,Diet and food preferences,X20675.Liking for hard cheese,18690,-0.0205129724662244,0.026104050817441,-0.0716769120684086,0.0306509671359599,0.431985452750358
CR2,Complement receptor type 2,Diet and food preferences,X20676.Liking for herring,18690,-0.0422398175811816,0.0251886515415679,-0.0916095746026547,0.00712993944029153,0.0935712671374302
CR2,Complement receptor type 2,Diet and food preferences,X20677.Liking for honey,18690,-0.00233587370469133,0.0255678921566865,-0.0524489423317969,0.0477771949224143,0.927207801737028
CR2,Complement receptor type 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18690,-0.0623868240693249,0.0251951743390628,-0.111769365773888,-0.0130042823647617,0.0132898808149624
CR2,Complement receptor type 2,Diet and food preferences,X20679.Liking for ice cream,18690,0.0157004535076722,0.0254803163697612,-0.0342409665770597,0.0656418735924041,0.537783443186279
CR2,Complement receptor type 2,Diet and food preferences,X20680.Liking for jam,18690,0.023876330448743,0.0253221137487873,-0.0257550124988801,0.0735076733963661,0.345742047697902
CR2,Complement receptor type 2,Diet and food preferences,X20681.Liking for kiwi fruit,18690,0.0506896305875589,0.0254411774681374,0.000824922750009574,0.100554338425108,0.0463390168517023
CR2,Complement receptor type 2,Diet and food preferences,X20682.Liking for lager,18690,-0.134413948158608,0.0254675335021554,-0.184330313822833,-0.0844975824943836,1.3216597018217e-07
CR2,Complement receptor type 2,Diet and food preferences,X20683.Liking for lamb,18690,-0.0561850657710343,0.0256512553312152,-0.106461526220216,-0.00590860532185242,0.0285116445327213
CR2,Complement receptor type 2,Diet and food preferences,X20684.Liking for lemons,18690,-0.0176485763886486,0.0255554555922227,-0.067737269349405,0.0324401165721078,0.489826056645053
CR2,Complement receptor type 2,Diet and food preferences,X20685.Liking for lentils or beans,18690,0.0281400924642637,0.0255024379587503,-0.0218446859348869,0.0781248708634144,0.269855765255965
CR2,Complement receptor type 2,Diet and food preferences,X20686.Liking for liver,18690,-0.0449689118380348,0.0254968050124743,-0.0949426496624844,0.00500482598641472,0.0777975565277932
CR2,Complement receptor type 2,Diet and food preferences,X20687.Liking for mackerel,18690,-0.0508183088004432,0.0253395985481403,-0.100483921954798,-0.00115269564608825,0.0449251062832042
CR2,Complement receptor type 2,Diet and food preferences,X20688.Liking for marzipan,18690,-0.0145628205426308,0.0252882085181685,-0.0641277092382411,0.0350020681529796,0.56470732635684
CR2,Complement receptor type 2,Diet and food preferences,X20689.Liking for mayonnaise,18690,-0.0380708592225784,0.0254674489343219,-0.0879870591338494,0.0118453406886926,0.134961855278422
CR2,Complement receptor type 2,Diet and food preferences,X20690.Liking for melon,18690,0.0506487713954235,0.0261671627334061,-0.00063886756205233,0.101936410352899,0.0529336135384518
CR2,Complement receptor type 2,Diet and food preferences,X20691.Liking for milk chocolate,18690,-0.00302959238196936,0.0253612278262331,-0.0527375989213863,0.0466784141574476,0.904914084845752
CR2,Complement receptor type 2,Diet and food preferences,X20692.Liking for mushrooms,18690,-0.00943686603382455,0.0260894361626193,-0.0605721609125584,0.0416984288449093,0.717571241048266
CR2,Complement receptor type 2,Diet and food preferences,X20694.Liking for orange juice,18690,-0.0115514734579897,0.0253518887224774,-0.0612411753540454,0.038138228438066,0.648650234340481
CR2,Complement receptor type 2,Diet and food preferences,X20695.Liking for oranges,18690,0.0296240706299239,0.0258561977620523,-0.0210540769836986,0.0803022182435463,0.251923988800249
CR2,Complement receptor type 2,Diet and food preferences,X20696.Liking for pasta,18690,0.0311180168861139,0.025574978400194,-0.0190089407782663,0.0812449745504941,0.223719763490701
CR2,Complement receptor type 2,Diet and food preferences,X20697.Liking for pears,18690,0.0677471955678364,0.0258232147237666,0.0171336947092539,0.118360696426419,0.00871023000133602
CR2,Complement receptor type 2,Diet and food preferences,X20698.Liking for pizza,18690,0.0101579784157648,0.0254068356979353,-0.0396394195521883,0.0599553763837179,0.689298968258219
CR2,Complement receptor type 2,Diet and food preferences,X20699.Liking for plain yogurt,18690,0.0206424770306539,0.0253793994048637,-0.029101145802879,0.0703860998641867,0.416024572659035
CR2,Complement receptor type 2,Diet and food preferences,X20700.Liking for plums,18690,0.065119291952599,0.0259375698719873,0.0142816550035038,0.115956928901694,0.012060437032201
CR2,Complement receptor type 2,Diet and food preferences,X20701.Liking for pollock,18690,-0.0510418585269597,0.025191455354825,-0.100417111022417,-0.00166660603150264,0.0427628302498344
CR2,Complement receptor type 2,Diet and food preferences,X20702.Liking for pork chop,18690,-0.0376695673030237,0.0254646080371078,-0.087580199055755,0.0122410644497076,0.13907941263962
CR2,Complement receptor type 2,Diet and food preferences,X20703.Liking for porridge,18690,0.0736219307247546,0.0257802097229585,0.023092719667756,0.124151141781753,0.00429821582741227
CR2,Complement receptor type 2,Diet and food preferences,X20704.Liking for potato crisps,18690,0.00849754811536857,0.0254662853173648,-0.0414163711066664,0.0584114673374036,0.738626034859709
CR2,Complement receptor type 2,Diet and food preferences,X20705.Liking for potatoes,18690,0.0263388843637682,0.02581628859146,-0.0242610412754935,0.0769388100030298,0.30762651183519
CR2,Complement receptor type 2,Diet and food preferences,X20706.Liking for prawns,18690,-0.0467643490667575,0.0256886564817385,-0.097114115770965,0.00358541763744994,0.0687098589025151
CR2,Complement receptor type 2,Diet and food preferences,X20707.Liking for raw carrots,18690,0.0471062503050692,0.0256241064556334,-0.00311699834797238,0.0973294989581107,0.0660257251008896
CR2,Complement receptor type 2,Diet and food preferences,X20708.Liking for red meat,18690,-0.0506573559119011,0.0255236474545489,-0.100683704922817,-0.000631006900985234,0.0471899754044861
CR2,Complement receptor type 2,Diet and food preferences,X20709.Liking for red wine,18690,-0.173505263918009,0.025418969790384,-0.223326444707161,-0.123684083128856,9.01115267832579e-12
CR2,Complement receptor type 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18690,-0.0004034449431493,0.0262046137090489,-0.0517644878128852,0.0509575979265866,0.987716458381814
CR2,Complement receptor type 2,Diet and food preferences,X20711.Liking for roast chicken,18690,0.0245818342517957,0.0266314484594508,-0.0276158047287279,0.0767794732323194,0.355999424336824
CR2,Complement receptor type 2,Diet and food preferences,X20712.Liking for salad dressing,18690,-0.0501619257424882,0.0253729234774708,-0.099892855758331,-0.000430995726645317,0.048057853585691
CR2,Complement receptor type 2,Diet and food preferences,X20713.Liking for salad leaves,18690,0.0374581566685488,0.0259724853217004,-0.0134479145619839,0.0883642278990816,0.149255806377286
CR2,Complement receptor type 2,Diet and food preferences,X20714.Liking for salami,18690,-0.0645192612092123,0.0252377195438586,-0.113985191515175,-0.0150533309032495,0.0105821162902116
CR2,Complement receptor type 2,Diet and food preferences,X20715.Liking for salmon,18690,0.0117447117414955,0.0266012139007824,-0.0403936675040381,0.0638830909870291,0.658848671146015
CR2,Complement receptor type 2,Diet and food preferences,X20716.Liking for salty foods,18690,-0.0228078353363386,0.02525580612697,-0.0723092153451998,0.0266935446725226,0.366498832348211
CR2,Complement receptor type 2,Diet and food preferences,X20717.Liking for salty pretzels,18690,-0.0411311541604702,0.0253319431499152,-0.0907817627343041,0.00851945441336368,0.104459449399338
CR2,Complement receptor type 2,Diet and food preferences,X20718.Liking for sardines,18690,-0.0357749944921629,0.0252580408386818,-0.0852807545359792,0.0137307655516534,0.156680839844168
CR2,Complement receptor type 2,Diet and food preferences,X20719.Liking for sausages (meat),18690,-0.0432469467651721,0.0255267782345283,-0.0932794321048475,0.00678553857450336,0.0902478429305767
CR2,Complement receptor type 2,Diet and food preferences,X20720.Liking for savoury biscuits,18690,-0.0395071533597972,0.0255555012863386,-0.0895959358810208,0.0105816291614264,0.122137128986389
CR2,Complement receptor type 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18690,-0.0814925959022976,0.0252653072921026,-0.131012598194819,-0.0319725936097765,0.00125980723057108
CR2,Complement receptor type 2,Diet and food preferences,X20722.Liking for skimmed milk,18690,-0.0028824712062401,0.025294928199136,-0.0524605304765466,0.0466955880640664,0.909275077921513
CR2,Complement receptor type 2,Diet and food preferences,X20723.Liking for smoked fish,18690,-0.0280151434486905,0.0253070304176894,-0.0776169230673618,0.0215866361699807,0.268303737975547
CR2,Complement receptor type 2,Diet and food preferences,X20724.Liking for soft cheese,18690,-0.027522604057633,0.0253832741865274,-0.0772738214632268,0.0222286133479607,0.278254193228278
CR2,Complement receptor type 2,Diet and food preferences,X20725.Liking for soy sauce,18690,-0.0756138261798996,0.0254310482635126,-0.125458680776384,-0.025768971583415,0.00295004318778823
CR2,Complement receptor type 2,Diet and food preferences,X20726.Liking for soya milk,18690,0.0660637709750885,0.0256150746796159,0.0158582246030414,0.116269317347136,0.00991346733390361
CR2,Complement receptor type 2,Diet and food preferences,X20727.Liking for spicy foods,18690,-0.128960214212273,0.0253565087754782,-0.17865897141221,-0.0792614570123358,3.69463771611808e-07
CR2,Complement receptor type 2,Diet and food preferences,X20728.Liking for spinach,18690,0.0144903323163526,0.0256006622535077,-0.0356869657005226,0.0646676303332277,0.571391092017263
CR2,Complement receptor type 2,Diet and food preferences,X20729.Liking for spirits,18690,-0.157536783774765,0.025259716001129,-0.207045827136978,-0.108027740412552,4.56558423650986e-10
CR2,Complement receptor type 2,Diet and food preferences,X20730.Liking for strawberries,18690,0.054629966348298,0.0277057034686252,0.000326787549792533,0.108933145146803,0.0486477599442383
CR2,Complement receptor type 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18690,0.014754725800334,0.0260056552274105,-0.0362163584453906,0.0657258100460585,0.570472335741844
CR2,Complement receptor type 2,Diet and food preferences,X20732.Liking for sweet foods,18690,0.0267968519240488,0.0253020360899353,-0.0227951388122245,0.076388842660322,0.289577563443492
CR2,Complement receptor type 2,Diet and food preferences,X20733.Liking for taking the stairs,18690,-0.00387854893129096,0.0258643514994149,-0.0545726778701441,0.0468155800075622,0.880799905279415
CR2,Complement receptor type 2,Diet and food preferences,X20734.Liking for tea with sugar,18690,0.00669793665518657,0.0306950360418294,-0.053464333986799,0.0668602072971722,0.827268568586723
CR2,Complement receptor type 2,Diet and food preferences,X20735.Liking for tea without sugar,18690,0.0206005242766838,0.0265477380301503,-0.0314330422624109,0.0726340908157784,0.43777039190755
CR2,Complement receptor type 2,Diet and food preferences,X20736.Liking for tomato ketchup,18690,-0.0235817667628799,0.0253170519492027,-0.0732031885833172,0.0260396550575574,0.35162882470273
CR2,Complement receptor type 2,Diet and food preferences,X20737.Liking for tinned tuna,18690,-0.00271950868474451,0.0255003642268043,-0.0527002225692809,0.0472612051997919,0.915071068210168
CR2,Complement receptor type 2,Diet and food preferences,X20738.Liking for turnip (white),18690,-0.0272611658726963,0.0252796172718639,-0.0768092157255496,0.022286883980157,0.280875810280683
CR2,Complement receptor type 2,Diet and food preferences,X20739.Liking for vegetables,18690,0.0489537611854642,0.0280874132400976,-0.00609756876512701,0.104005091136056,0.0813662520494073
CR2,Complement receptor type 2,Diet and food preferences,X20740.Liking for vinegar,18690,-0.0216866373342741,0.025555466495802,-0.0717753516660461,0.0284020769974979,0.396108941154103
CR2,Complement receptor type 2,Diet and food preferences,X20741.Liking for watching television,18690,0.0507843605667977,0.0255787955426163,0.000649921303269692,0.100918799830326,0.0471136383829403
CR2,Complement receptor type 2,Diet and food preferences,X20742.Liking for whisky,18690,-0.138561284638957,0.0260726104358688,-0.189663601093259,-0.0874589681846538,1.08215261629187e-07
CR2,Complement receptor type 2,Diet and food preferences,X20743.Liking for white bread,18690,0.0086787744536989,0.0252670108493125,-0.0408445668109536,0.0582021157183514,0.731239419870097
CR2,Complement receptor type 2,Diet and food preferences,X20744.Liking for white rice,18690,-0.0122860614711423,0.0256266073817289,-0.062514211939331,0.0379420889970463,0.631641228152988
CR2,Complement receptor type 2,Diet and food preferences,X20745.Liking for white wine,18690,-0.157686777177764,0.0252489083666943,-0.207174637576485,-0.108198916779043,4.32152729993175e-10
CR2,Complement receptor type 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18690,0.0588562167377793,0.0256532277843177,0.00857589028051663,0.109136543195042,0.021784284804691
CR2,Complement receptor type 2,Diet and food preferences,X20747.Liking for whole milk,18690,0.00688746490368239,0.0251293671159355,-0.0423660946435512,0.056141024450916,0.784025932340512
CR2,Complement receptor type 2,Diet and food preferences,X20748.Liking for wholemeal bread,18690,-0.0095900406556962,0.0265259497025797,-0.0615809020727524,0.04240082076136,0.717704160647225
CR2,Complement receptor type 2,Diet and food preferences,X20749.Liking for working up a sweat,18690,-0.0775923799827803,0.0254111494064924,-0.127398232819505,-0.0277865271460552,0.00226523882323635
CR2,Complement receptor type 2,Physical measures,X21001.Body mass index (BMI),51467,-0.0457103041251673,0.010170660316615,-0.0656447983457327,-0.0257758099046019,6.99412527064562e-06
CR2,Complement receptor type 2,Physical measures,X21002.Weight,51507,0.0206109299172974,0.00573164186042273,0.00937691187086884,0.031844947963726,0.000323461610568953
CR2,Complement receptor type 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,17123,0.00684916709154314,0.00423030562110272,-0.0014422319258182,0.0151405661089045,0.10545032071007
CR2,Complement receptor type 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17857,0.0357559105649507,0.0271169603545974,-0.0173933317300603,0.0889051528599616,0.187326134996253
CR2,Complement receptor type 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17873,-0.0602710639129979,0.0280546286095872,-0.115258135987789,-0.00528399183820701,0.0316996459630644
CR2,Complement receptor type 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17875,0.0500300421413792,0.0276470078639636,-0.0041580932719895,0.104218177554748,0.0703745516388497
CR2,Complement receptor type 2,Health and medical history,X21040.Satisfaction with bowel habits,17799,0.0075484086940688,0.0256342143604576,-0.0426946514524281,0.0577914688405657,0.768405155760348
CR2,Complement receptor type 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17781,0.0696982148612961,0.0273197839261086,0.0161514383661232,0.123244991356469,0.0107435989536692
CR2,Complement receptor type 2,Health and medical history,X21042.Greatest number of times bowels opened per day,17788,0.00516524964509064,0.0276255716871796,-0.0489808708617814,0.0593113701519626,0.851683549812433
CR2,Complement receptor type 2,Health and medical history,X21043.Least number of times bowels opened per week,17662,-0.00483511325761367,0.0273697168621796,-0.0584797583074856,0.0488095317922583,0.859778089777148
CR2,Complement receptor type 2,Health and medical history,X21044.Average number of times bowels opened per day,17727,0.033883691966594,0.0308449129048595,-0.0265723373269306,0.0943397212601186,0.271993301188317
CR2,Complement receptor type 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17884,-0.000159802908655029,0.0280630481820779,-0.0551633773455277,0.0548437715282177,0.995456594743879
CR2,Complement receptor type 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17874,0.00624399431439966,0.0281300192801669,-0.0488908434747274,0.0613788321035267,0.824340496690566
CR2,Complement receptor type 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10047,0.0546860199735084,0.0435400396383049,-0.0306524577175693,0.140024497664586,0.209147466207478
CR2,Complement receptor type 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17879,0.00722532051978752,0.0305420945450502,-0.0526371847885109,0.067087825828086,0.812993687386302
CR2,Complement receptor type 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17876,-0.0268613512612024,0.0422343745477083,-0.109640725374711,0.0559180228523059,0.524780110522439
CR2,Complement receptor type 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17878,-0.0284471738973223,0.032880440540696,-0.0928928373570864,0.0359984895624419,0.386957054630573
CR2,Complement receptor type 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17875,-0.032508693987536,0.0815835344297577,-0.192412421469861,0.127395033494789,0.690287600575878
CR2,Complement receptor type 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17883,-0.013455612703075,0.0319978726905665,-0.0761714431765853,0.0492602177704352,0.674113708498142
CR2,Complement receptor type 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17879,-0.0535278920738851,0.031893381479758,-0.116038919774211,0.00898313562644045,0.0932985147370259
CR2,Complement receptor type 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17469,0.0643714601385061,0.0290866286428143,0.0073616679985901,0.121381252278422,0.026904013854709
CR2,Complement receptor type 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17873,-0.0299434447517089,0.0286484723296795,-0.0860944505178809,0.026207561014463,0.295943699254848
CR2,Complement receptor type 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17880,-0.0453191348429748,0.0416379743102134,-0.126929564490993,0.0362912948050435,0.276429390335618
CR2,Complement receptor type 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17883,-0.069711404721408,0.0280382408680207,-0.124666356822729,-0.0147564526200873,0.0129170689758242
CR2,Complement receptor type 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17880,-0.0636938604659035,0.0279494284298897,-0.118474740188487,-0.00891298074331959,0.0226849506452196
CR2,Complement receptor type 2,Working and living environment,X21100.Water hardness (USGS classification),51196,0.026555394408406,0.0159825480891947,-0.00477039984641564,0.0578811886632277,0.0966142874033468
CR2,Complement receptor type 2,Lifestyle factors,X2139.Age first had sexual intercourse,44668,0.0213179116215977,0.00261895041292126,0.0161847688122721,0.0264510544309234,4.05843034535115e-16
CR2,Complement receptor type 2,Health and medical history,X2149.Lifetime number of sexual partners,41436,-0.112989462873328,0.0180897598862758,-0.148445392250429,-0.0775335334962277,4.25055127253267e-10
CR2,Complement receptor type 2,Physical activities,X22032.IPAQ activity group,41391,-0.064758529422847,0.017776207670405,-0.0995998964568408,-0.0299171623888533,0.000269819480591777
CR2,Complement receptor type 2,Physical activities,X22033.Summed days activity,42488,-0.0126130086824952,0.00254987675960992,-0.0176107671313307,-0.00761525023365979,7.58412450105403e-07
CR2,Complement receptor type 2,Physical activities,X22034.Summed minutes activity,41391,-0.00919267118195755,0.00257321577580613,-0.0142361741025376,-0.00414916826137753,0.000354065564145613
CR2,Complement receptor type 2,Physical activities,X22037.MET minutes per week for walking,39621,-0.005501099252177,0.0026229800183057,-0.0106421400880562,-0.000360058416297823,0.0359759381116132
CR2,Complement receptor type 2,Physical activities,X22038.MET minutes per week for moderate activity,41391,-0.00810829949106889,0.00257558934144056,-0.0131564546002924,-0.0030601443818454,0.00164433230784158
CR2,Complement receptor type 2,Physical activities,X22039.MET minutes per week for vigorous activity,41391,-0.102638180816272,0.0177819967230087,-0.137490894393369,-0.067785467239175,7.88812759909666e-09
CR2,Complement receptor type 2,Physical activities,X22040.Summed MET minutes per week for all activity,39621,-0.0106762466361688,0.00263442420602128,-0.0158397180799705,-0.00551277519236706,5.0749875522761e-05
CR2,Complement receptor type 2,Eye measures,X2217.Age started wearing glasses or contact lenses,43946,-0.00491603254737904,0.00255570905104306,-0.00992522228742344,9.31571926653628e-05,0.0544175462707892
CR2,Complement receptor type 2,Working and living environment,X22501.Year ended full time education,12549,-0.0183480608370946,0.0116400250877085,-0.0411625100090034,0.00446638833481413,0.114984107765
CR2,Complement receptor type 2,Lifestyle factors,X22506.Tobacco smoking,12466,0.00647110859285104,0.0667421139923263,-0.124343434832108,0.137285652017811,0.922762181164473
CR2,Complement receptor type 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48320,-0.194365721125848,0.0422616550597578,-0.277198565042973,-0.111532877208722,4.25388024939671e-06
CR2,Complement receptor type 2,Physical measures,X23098.Weight,50637,0.0223827974575732,0.00577449639785124,0.0110647845177847,0.0337008103973616,0.000106257317007473
CR2,Complement receptor type 2,Physical measures,X23099.Body fat percentage,50607,0.0107317600230563,0.00554892970114036,-0.00014414219117885,0.0216076622372914,0.0531158177239639
CR2,Complement receptor type 2,Physical measures,X23100.Whole body fat mass,50557,0.0206111105063702,0.00535618955431016,0.0101129789799223,0.0311092420328181,0.000119187553850973
CR2,Complement receptor type 2,Physical measures,X23101.Whole body fat-free mass,50632,0.0132383504936611,0.0048322886661899,0.00376706470792886,0.0227096362793933,0.00615428013435133
CR2,Complement receptor type 2,Physical measures,X23102.Whole body water mass,50637,0.0130004870823226,0.00483968959396924,0.00351469547814288,0.0224862786865023,0.00722883451832876
CR2,Complement receptor type 2,Physical measures,X23104.Body mass index (BMI),50637,-0.047639224326678,0.0102150594325122,-0.067660740814402,-0.027617707838954,3.11476884629612e-06
CR2,Complement receptor type 2,Physical measures,X23105.Basal metabolic rate,50635,0.0152920190005885,0.0051692146763549,0.00516035823493288,0.0254236797662441,0.00309497265574345
CR2,Complement receptor type 2,Physical measures,X23106.Impedance of whole body,50631,0.0123580575016048,0.00395707756538098,0.00460218547345804,0.0201139295297515,0.00179102616872636
CR2,Complement receptor type 2,Physical measures,X23107.Impedance of leg (right),50634,0.00974343936617415,0.00322810996857551,0.00341634382776615,0.0160705349045822,0.00254314459339345
CR2,Complement receptor type 2,Physical measures,X23108.Impedance of leg (left),50633,0.0089324797050016,0.00320605433993588,0.00264861319872728,0.0152163462112759,0.00533615482207482
CR2,Complement receptor type 2,Physical measures,X23109.Impedance of arm (right),50624,0.00778383716584036,0.00394344028116618,5.46942147546456e-05,0.0155129801169261,0.0484019940782146
CR2,Complement receptor type 2,Physical measures,X23110.Impedance of arm (left),50632,0.00926813337813936,0.00394798684265294,0.0015300791665396,0.0170061875897391,0.0189006925205916
CR2,Complement receptor type 2,Physical measures,X23111.Leg fat percentage (right),50633,0.00578932382992452,0.00670601355160633,-0.00735446273122388,0.0189331103910729,0.387974804142676
CR2,Complement receptor type 2,Physical measures,X23112.Leg fat mass (right),50632,0.0357450974553487,0.00712657372224274,0.0217770129597529,0.0497131819509444,5.30058577026056e-07
CR2,Complement receptor type 2,Physical measures,X23113.Leg fat-free mass (right),50631,0.0168483756005366,0.00505444770113982,0.00694165810630254,0.0267550930947706,0.00085860359643036
CR2,Complement receptor type 2,Physical measures,X23114.Leg predicted mass (right),50630,0.0167312399012036,0.00507968223815306,0.00677506271442362,0.0266874170879836,0.000989256585535568
CR2,Complement receptor type 2,Physical measures,X23115.Leg fat percentage (left),50627,0.00195036956444442,0.00699057802644903,-0.0117511633673957,0.0156519024962845,0.780246151847499
CR2,Complement receptor type 2,Physical measures,X23116.Leg fat mass (left),50627,0.0329948953047858,0.00743627745358645,0.0184197914957563,0.0475699991138152,9.14059595084672e-06
CR2,Complement receptor type 2,Physical measures,X23117.Leg fat-free mass (left),50624,0.021200024061353,0.00527648381728157,0.0108581157794811,0.0315419323432248,5.88209457790044e-05
CR2,Complement receptor type 2,Physical measures,X23118.Leg predicted mass (left),50623,0.0210856833515276,0.00530286419753785,0.0106920695243534,0.0314792971787018,7.00983134855455e-05
CR2,Complement receptor type 2,Physical measures,X23119.Arm fat percentage (right),50623,-0.011125933389292,0.00615675305812049,-0.0231931693832082,0.000941302604624116,0.0707509804631089
CR2,Complement receptor type 2,Physical measures,X23120.Arm fat mass (right),50618,0.00446871261809605,0.00609648797158137,-0.00748040380620343,0.0164178290423955,0.463563131793572
CR2,Complement receptor type 2,Physical measures,X23121.Arm fat-free mass (right),50619,0.0202377530896259,0.0048667624447611,0.0106988986978942,0.0297766074813577,3.21067283696413e-05
CR2,Complement receptor type 2,Physical measures,X23122.Arm predicted mass (right),50618,0.0209216859990612,0.00487416682865382,0.0113683190148997,0.0304750529832227,1.77111102912634e-05
CR2,Complement receptor type 2,Physical measures,X23123.Arm fat percentage (left),50613,-0.00479256615901587,0.00631420631286274,-0.0171684105322268,0.00758327821419509,0.447848175420297
CR2,Complement receptor type 2,Physical measures,X23124.Arm fat mass (left),50612,0.0067164921753556,0.00608469685112054,-0.00520951365284065,0.0186424980035519,0.269670622787652
CR2,Complement receptor type 2,Physical measures,X23125.Arm fat-free mass (left),50608,0.0157203465604712,0.00496140526259078,0.00599599224579323,0.0254447008751491,0.00153304631550098
CR2,Complement receptor type 2,Physical measures,X23126.Arm predicted mass (left),50605,0.0136558989817743,0.00497904683653718,0.0038969671821614,0.0234148307813871,0.0060962712736845
CR2,Complement receptor type 2,Physical measures,X23127.Trunk fat percentage,50601,0.00987392703321895,0.0039769277942903,0.00207914855640997,0.0176687055100279,0.0130385434783696
CR2,Complement receptor type 2,Physical measures,X23128.Trunk fat mass,50597,0.0182753002745272,0.00437487621977776,0.00970054288376279,0.0268500576652916,2.95445455601519e-05
CR2,Complement receptor type 2,Physical measures,X23129.Trunk fat-free mass,50590,0.00705569275656022,0.00438153667904169,-0.00153211913436149,0.0156435046474819,0.107333428629199
CR2,Complement receptor type 2,Physical measures,X23130.Trunk predicted mass,50585,0.00751155826595147,0.00438403419511459,-0.00108114875647313,0.0161042652883761,0.0866470309716786
CR2,Complement receptor type 2,NMR metabolomics,X23400.Total Cholesterol,29594,-0.0293016231531645,0.00316839509662374,-0.035511677542547,-0.023091568763782,2.43420729366124e-20
CR2,Complement receptor type 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29594,-0.00922810457299101,0.00307461865897401,-0.0152543571445801,-0.00320185200140196,0.00268981478270585
CR2,Complement receptor type 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29594,-0.00183636729402409,0.00307977756173848,-0.00787273131503152,0.00419999672698333,0.551001963327309
CR2,Complement receptor type 2,NMR metabolomics,X23403.VLDL Cholesterol,29594,0.0181325339213836,0.0030848227320205,0.0120862813666234,0.0241787864761438,4.19746866228699e-09
CR2,Complement receptor type 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,29594,-0.0155342077949232,0.00307854077240866,-0.0215681477088442,-0.00950026788100224,4.53909049173807e-07
CR2,Complement receptor type 2,NMR metabolomics,X23405.LDL Cholesterol,29594,-0.0154588519178004,0.00306914190088185,-0.0214743700435288,-0.00944333379207195,4.76000197780418e-07
CR2,Complement receptor type 2,NMR metabolomics,X23406.HDL Cholesterol,29594,-0.0783940766174512,0.00354166652929908,-0.0853357430148774,-0.071452410220025,1.09622194458427e-107
CR2,Complement receptor type 2,NMR metabolomics,X23407.Total Triglycerides,29594,0.021143421713386,0.00326591655593224,0.0147422252637588,0.0275446181630132,9.6959998366892e-11
CR2,Complement receptor type 2,NMR metabolomics,X23408.Triglycerides in VLDL,29594,0.0250262933590184,0.00328965704699115,0.0185785655469158,0.0314740211711211,2.8758704343288e-14
CR2,Complement receptor type 2,NMR metabolomics,X23409.Triglycerides in LDL,29594,0.00463693764571255,0.00316627030904041,-0.00156895216000665,0.0108428274514317,0.143073634663331
CR2,Complement receptor type 2,NMR metabolomics,X23410.Triglycerides in HDL,29594,0.00747305958796271,0.00315113175203354,0.00129684135397697,0.0136492778219484,0.0177201199022725
CR2,Complement receptor type 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29594,-0.0381416787465841,0.00321132720598895,-0.0444358800703224,-0.0318474774228457,1.84236164496476e-32
CR2,Complement receptor type 2,NMR metabolomics,X23412.Phospholipids in VLDL,29594,0.0232795093725039,0.00315460047007641,0.0170964924511541,0.0294625262938536,1.63008999123776e-13
CR2,Complement receptor type 2,NMR metabolomics,X23413.Phospholipids in LDL,29594,-0.0135440290208746,0.00306305190031793,-0.0195476107454977,-0.00754044729625143,9.8256332047591e-06
CR2,Complement receptor type 2,NMR metabolomics,X23414.Phospholipids in HDL,29594,-0.0675719153320235,0.00342271358693373,-0.0742804339624136,-0.0608633967016334,3.36398754107695e-86
CR2,Complement receptor type 2,NMR metabolomics,X23415.Total Esterified Cholesterol,29594,-0.0334901152489962,0.00318309691922625,-0.0397289852106797,-0.0272512452873128,7.6610211327759e-26
CR2,Complement receptor type 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29594,0.015501514492684,0.00306781121675244,0.00948860450784925,0.0215144244775188,4.37612590296323e-07
CR2,Complement receptor type 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29594,-0.0133343990772431,0.00306298228443949,-0.0193378443547445,-0.00733095379974173,1.34489475179613e-05
CR2,Complement receptor type 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29594,-0.079699823894958,0.00352899910086825,-0.0866166621326598,-0.0727829856572563,5.48752685632669e-112
CR2,Complement receptor type 2,NMR metabolomics,X23419.Total Free Cholesterol,29594,-0.018605101532753,0.00313313091641742,-0.0247460381289312,-0.0124641649365749,2.91413784097494e-09
CR2,Complement receptor type 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,29594,0.0211857257670552,0.00312555330377274,0.0150596412916606,0.0273118102424498,1.23938128827772e-11
CR2,Complement receptor type 2,NMR metabolomics,X23421.Free Cholesterol in LDL,29594,-0.0207488671541605,0.00309909386494356,-0.0268230911294499,-0.0146746431788712,2.19316185787205e-11
CR2,Complement receptor type 2,NMR metabolomics,X23422.Free Cholesterol in HDL,29594,-0.0688679626687133,0.00354598405429879,-0.0758180914151389,-0.0619178339222877,1.68721934306342e-83
CR2,Complement receptor type 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29594,-0.01928999843538,0.00310558048309098,-0.0253769361822383,-0.0132030606885216,5.32136135838649e-10
CR2,Complement receptor type 2,NMR metabolomics,X23424.Total Lipids in VLDL,29594,0.0243864458245179,0.00319505777338197,0.0181241325886892,0.0306487590603465,2.37070274016328e-14
CR2,Complement receptor type 2,NMR metabolomics,X23425.Total Lipids in LDL,29594,-0.0140109814470288,0.00306489152796056,-0.0200181688418315,-0.00800379405222607,4.86332721381202e-06
CR2,Complement receptor type 2,NMR metabolomics,X23426.Total Lipids in HDL,29594,-0.0708704312605513,0.00346888311430899,-0.0776694421645969,-0.0640714203565057,3.89295066990733e-92
CR2,Complement receptor type 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29594,-0.067398521170014,0.00325465347398273,-0.0737776419790202,-0.0610194003610079,1.36745047692715e-94
CR2,Complement receptor type 2,NMR metabolomics,X23428.Concentration of VLDL Particles,29594,0.0187948031125903,0.00311065568864575,0.0126979179628446,0.0248916882623359,1.53964191411492e-09
CR2,Complement receptor type 2,NMR metabolomics,X23429.Concentration of LDL Particles,29594,0.00250334360853081,0.00305786012786319,-0.00349006224208103,0.00849674945914265,0.412987796367074
CR2,Complement receptor type 2,NMR metabolomics,X23430.Concentration of HDL Particles,29594,-0.0712696371070037,0.00326380099929319,-0.0776666870656184,-0.064872587148389,7.06512726198651e-105
CR2,Complement receptor type 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29594,0.0314515708659683,0.00341480305380194,0.0247585568805165,0.0381445848514201,3.45862155243891e-20
CR2,Complement receptor type 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,29594,-0.029253050490175,0.00319411446671385,-0.0355135148449341,-0.0229925861354158,5.59600457523364e-20
CR2,Complement receptor type 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,29594,-0.0403065556063614,0.00364906047137607,-0.0474587141302585,-0.0331543970824643,2.61142542286565e-28
CR2,Complement receptor type 2,NMR metabolomics,X23434.Phosphoglycerides,29570,-0.0422692028838573,0.00323132256889658,-0.0486025951188946,-0.03593581064882,5.42116192926682e-39
CR2,Complement receptor type 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29570,0.0486654029574701,0.0034584821206066,0.0418867780010812,0.0554440279138591,7.95564734297187e-45
CR2,Complement receptor type 2,NMR metabolomics,X23436.Total Cholines,29570,-0.0441196836558182,0.00325915904728057,-0.0505076353884881,-0.0377317319231483,1.25646312919224e-41
CR2,Complement receptor type 2,NMR metabolomics,X23437.Phosphatidylcholines,29570,-0.0470313726863405,0.00326998652531477,-0.0534405462759575,-0.0406221990967236,9.554642072764e-47
CR2,Complement receptor type 2,NMR metabolomics,X23438.Sphingomyelins,29569,-0.0442572629442818,0.00328345091873939,-0.050692826745011,-0.0378216991435526,2.75818390831601e-41
CR2,Complement receptor type 2,NMR metabolomics,X23439.Apolipoprotein B,29594,0.00275404021380832,0.00306133290467802,-0.00324617227936059,0.00875425270697723,0.368329154195885
CR2,Complement receptor type 2,NMR metabolomics,X23440.Apolipoprotein A1,29594,-0.0709391526061711,0.00337547427692052,-0.0775550821889353,-0.0643232230234069,2.41098249432209e-97
CR2,Complement receptor type 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29594,0.0370932153167851,0.00311908094798567,0.0309798166587332,0.043206613974837,1.5386900065248e-32
CR2,Complement receptor type 2,NMR metabolomics,X23442.Total Fatty Acids,29570,-0.0091017127223398,0.0031161906604867,-0.0152094464168937,-0.00299397902778587,0.00349418283861876
CR2,Complement receptor type 2,NMR metabolomics,X23443.Degree of Unsaturation,29570,-0.0174866173906366,0.00337141995299692,-0.0240946004985106,-0.0108786342827627,2.15438073351369e-07
CR2,Complement receptor type 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,29570,-0.00778538101321868,0.00317976936122447,-0.0140177289612186,-0.00155303306521873,0.0143545734335964
CR2,Complement receptor type 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,29570,-0.0172076201525121,0.00311774107656848,-0.0233183926625863,-0.0110968476424379,3.43287554095355e-08
CR2,Complement receptor type 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29570,-0.0169364000681229,0.00313324172620438,-0.0230775538514835,-0.0107952462847624,6.51668725064856e-08
CR2,Complement receptor type 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29570,0.0041509247705826,0.00319442220987522,-0.00211014276077282,0.010411992301938,0.193806889465122
CR2,Complement receptor type 2,NMR metabolomics,X23448.Saturated Fatty Acids,29570,-0.0136651463586461,0.00313200515939589,-0.0198038764710621,-0.00752641624623018,1.28686234140025e-05
CR2,Complement receptor type 2,NMR metabolomics,X23449.Linoleic Acid,29570,-0.00835522426757469,0.00310640506636021,-0.0144437781976407,-0.00226667033750868,0.00715614957875104
CR2,Complement receptor type 2,NMR metabolomics,X23450.Docosahexaenoic Acid,29570,-0.0273401421042913,0.00326542044232256,-0.0337403661712435,-0.020939918037339,5.8805384938069e-17
CR2,Complement receptor type 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29570,-0.00438514469414688,0.00320669035275327,-0.0106702577855433,0.00189996839724953,0.171479461969118
CR2,Complement receptor type 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29570,-0.00534683459155522,0.00333716226538826,-0.0118876726317162,0.00119400344860576,0.109119876577001
CR2,Complement receptor type 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29570,-0.00609565903469509,0.00340116537776306,-0.0127619431751107,0.000570625105720507,0.0731069008513292
CR2,Complement receptor type 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29570,0.032556384465053,0.00345493227396018,0.0257847172080911,0.039328051722015,4.68530239144538e-21
CR2,Complement receptor type 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29570,-0.0220810470621858,0.0031299847325226,-0.0282158171379301,-0.0159462769864415,1.76801742205594e-12
CR2,Complement receptor type 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29570,0.0030445030683734,0.00333339107718703,-0.00348894344291318,0.00957794957965997,0.361073778186827
CR2,Complement receptor type 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29570,-0.0210666714504749,0.00328314640157052,-0.0275016383975531,-0.0146317045033967,1.41449831292711e-10
CR2,Complement receptor type 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29570,-0.0222868318101069,0.00345982037625797,-0.0290680797475725,-0.0155055838726413,1.20024449791459e-10
CR2,Complement receptor type 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29568,0.00126926870121854,0.00317360903406869,-0.0049510050055561,0.00748954240799317,0.689200001875887
CR2,Complement receptor type 2,NMR metabolomics,X23460.Alanine,29584,0.00784351102990944,0.00310706427244466,0.0017536650559179,0.013933357003901,0.0115943828094273
CR2,Complement receptor type 2,NMR metabolomics,X23461.Glutamine,29497,-0.00185812237389317,0.00309563507784842,-0.00792556712647607,0.00420932237868973,0.54835126249787
CR2,Complement receptor type 2,NMR metabolomics,X23462.Glycine,29559,0.0109969528175223,0.00327202477949772,0.00458378424970681,0.0174101213853379,0.000777869304315002
CR2,Complement receptor type 2,NMR metabolomics,X23463.Histidine,29556,-0.000170364483178696,0.00307067075498894,-0.00618887916295702,0.00584815019659963,0.95575548621516
CR2,Complement receptor type 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29573,0.0142490370298921,0.00325893454445643,0.00786152532275752,0.0206365487370267,1.2336443664774e-05
CR2,Complement receptor type 2,NMR metabolomics,X23465.Isoleucine,29588,0.0111308263849149,0.0031794536906006,0.00489909715133775,0.0173625556184921,0.000464440101671838
CR2,Complement receptor type 2,NMR metabolomics,X23466.Leucine,29589,0.0101235829553973,0.00324978698181757,0.0037540004710349,0.0164931654397598,0.0018402539611555
CR2,Complement receptor type 2,NMR metabolomics,X23467.Valine,29573,0.016361510009879,0.00326448286043203,0.00996312360343218,0.0227598964163257,5.41846879363861e-07
CR2,Complement receptor type 2,NMR metabolomics,X23468.Phenylalanine,29582,0.0132710751977384,0.0031058730903938,0.00718356394056656,0.0193585864549103,1.93552730738958e-05
CR2,Complement receptor type 2,NMR metabolomics,X23469.Tyrosine,29560,0.0176503584995532,0.00315829216974405,0.0114601058468549,0.0238406111522516,2.30954533563434e-08
CR2,Complement receptor type 2,NMR metabolomics,X23470.Glucose,29539,0.0194289049980632,0.00312214807598233,0.0133094947691378,0.0255483152269886,4.94509598944722e-10
CR2,Complement receptor type 2,NMR metabolomics,X23471.Lactate,29540,-0.000276974954276535,0.00309636794460383,-0.00634585612570004,0.00579190621714697,0.928723652525756
CR2,Complement receptor type 2,NMR metabolomics,X23472.Pyruvate,29496,-0.0161660757310943,0.00309576202517622,-0.0222337693004397,-0.0100983821617489,1.78199104490242e-07
CR2,Complement receptor type 2,NMR metabolomics,X23473.Citrate,29589,0.0221294704510988,0.00313300671692292,0.0159887772859299,0.0282701636162677,1.66146559821731e-12
CR2,Complement receptor type 2,NMR metabolomics,X23474.3-Hydroxybutyrate,29116,-0.016166673245179,0.0031487911555666,-0.0223383039100896,-0.00999504258026847,2.85097206265485e-07
CR2,Complement receptor type 2,NMR metabolomics,X23475.Acetate,29568,0.0118655001979192,0.00308854069452593,0.00581196043664834,0.01791903995919,0.000122399371235735
CR2,Complement receptor type 2,NMR metabolomics,X23476.Acetoacetate,29592,-0.0186814244392063,0.00309169986107649,-0.0247411561669163,-0.0126216927114964,1.53608943005098e-09
CR2,Complement receptor type 2,NMR metabolomics,X23477.Acetone,29592,-0.0227699033831173,0.00308787233883396,-0.0288221331672319,-0.0167176735990028,1.69950676106018e-13
CR2,Complement receptor type 2,NMR metabolomics,X23478.Creatinine,28849,0.0346232422111654,0.00366342593480764,0.0274429273789425,0.0418035570433884,3.599571388371e-21
CR2,Complement receptor type 2,NMR metabolomics,X23479.Albumin,29590,0.0189763787921601,0.00312804647866854,0.0128454076939698,0.0251073498903505,1.32290750973376e-09
CR2,Complement receptor type 2,NMR metabolomics,X23480.Glycoprotein Acetyls,29594,0.00988530069898215,0.00328873401743189,0.00343938202481565,0.0163312193731487,0.00265098907222664
CR2,Complement receptor type 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29594,0.0316061109968959,0.00330010839030624,0.0251378985518956,0.0380743234418961,1.07110758721024e-21
CR2,Complement receptor type 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29594,0.032048886409581,0.00329357181691987,0.0255934856484181,0.038504287170744,2.40863930372169e-22
CR2,Complement receptor type 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29594,0.0322490641333499,0.00331364974126002,0.0257543106404802,0.0387438176262195,2.37465261755024e-22
CR2,Complement receptor type 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29594,0.0311885840069107,0.00328245073323861,0.024754980569763,0.0376221874440584,2.21702065375979e-21
CR2,Complement receptor type 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29594,0.0315981700091004,0.00326968652355826,0.0251895844229262,0.0380067555952746,4.62354102666056e-22
CR2,Complement receptor type 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29594,0.0298987209111775,0.00328461334004589,0.0234608787646876,0.0363365630576675,9.35312585011415e-20
CR2,Complement receptor type 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29594,0.0312099593578148,0.00327918091942638,0.0247827647557391,0.0376371539598905,1.90198758966112e-21
CR2,Complement receptor type 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29594,0.0299249976230566,0.00331552470938373,0.0234265691926645,0.0364234260534487,1.89055300631476e-19
CR2,Complement receptor type 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29594,0.0305410592410553,0.00330994586467013,0.0240535653463019,0.0370285531358088,2.96131992544696e-20
CR2,Complement receptor type 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29594,0.0326795542892266,0.00328996527337834,0.0262312223534051,0.0391278862250482,3.24922501495756e-23
CR2,Complement receptor type 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29594,0.030819375281755,0.0032212709927616,0.0245056841359423,0.0371330664275678,1.17770345682558e-21
CR2,Complement receptor type 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29594,0.0282585468852599,0.00317833950532129,0.0220290014548302,0.0344880923156896,6.39371371136842e-19
CR2,Complement receptor type 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29594,0.0325408981980761,0.00326192505249166,0.0261475250951924,0.0389342713009597,2.11442750758868e-23
CR2,Complement receptor type 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29594,0.0280056945901529,0.0033420473272602,0.0214552818287229,0.0345561073515829,5.53345284573225e-17
CR2,Complement receptor type 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29594,0.0284878375384208,0.00327419661959922,0.0220704121640063,0.0349052629128352,3.46591246920283e-18
CR2,Complement receptor type 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,29594,0.0275811092261138,0.00326808425621081,0.0211756640839406,0.033986554368287,3.32936820001789e-17
CR2,Complement receptor type 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,29594,0.0303790926657882,0.00328539254064872,0.0239397232861167,0.0368184620454597,2.4657403065101e-20
CR2,Complement receptor type 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,29594,0.0293905814382,0.00320614732890107,0.0231065326735539,0.0356746302028461,5.17203028326076e-20
CR2,Complement receptor type 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29594,0.0282924924524436,0.00314877752583816,0.0221208885018008,0.0344640964030864,2.73157119694755e-19
CR2,Complement receptor type 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29594,0.0297108997346816,0.0032700310916374,0.0233016387950723,0.0361201606742909,1.09165654876091e-19
CR2,Complement receptor type 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,29594,0.0237774077593928,0.00328288431620818,0.0173429544996248,0.0302118610191609,4.50105277346276e-13
CR2,Complement receptor type 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29594,0.0141753949660653,0.00308338454905438,0.00813196124991873,0.0202188286822119,4.29669083548645e-06
CR2,Complement receptor type 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29594,0.0157029298009203,0.0031086622414937,0.00960995180759263,0.0217959077942479,4.41313348977018e-07
CR2,Complement receptor type 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29594,0.0129558833116447,0.00307620874202043,0.00692651417728464,0.0189852524460047,2.54273053165791e-05
CR2,Complement receptor type 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29594,0.00443850584494929,0.0030693438519223,-0.00157740810481843,0.010454419794717,0.148166356777365
CR2,Complement receptor type 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29594,-0.000754850765861093,0.00310009942721087,-0.0068310456431944,0.00532134411147221,0.807625631414293
CR2,Complement receptor type 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29594,0.0106275837404839,0.00306501010226195,0.00462016394005043,0.0166350035409173,0.000526286398598626
CR2,Complement receptor type 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29594,0.0199359546023761,0.00322437984711046,0.0136161701020396,0.0262557391027126,6.37647156647848e-10
CR2,Complement receptor type 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29594,0.0230497884565236,0.00314800096831368,0.0168797065586288,0.0292198703544184,2.50452698908546e-13
CR2,Complement receptor type 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,29594,0.0200934208923234,0.0031368422486154,0.0139452100850372,0.0262416316996096,1.52007552888873e-10
CR2,Complement receptor type 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,29594,0.0140239990354821,0.00308471274430704,0.00797796205664033,0.0200700360143239,5.48159731583723e-06
CR2,Complement receptor type 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,29594,0.0160864151204146,0.00307599295050854,0.0100574689374178,0.0221153613034113,1.70970892986554e-07
CR2,Complement receptor type 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29594,0.0200323296149289,0.00308858028524814,0.0139787122558426,0.0260859469740153,8.95739954890316e-11
CR2,Complement receptor type 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29594,0.00871820212479585,0.00306326995178686,0.00271419301929362,0.0147222112302981,0.00442964633547001
CR2,Complement receptor type 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,29594,0.0221851122420908,0.00323428069523671,0.0158459220794268,0.0285243024047547,7.0527673774127e-12
CR2,Complement receptor type 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29594,0.00895552008011632,0.00310459054095524,0.00287052261984404,0.0150405175403886,0.00392186870120731
CR2,Complement receptor type 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29594,0.00804545610125266,0.00311498832329911,0.00194007898758639,0.0141508332149189,0.009804382232925
CR2,Complement receptor type 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29594,0.0122739753422612,0.00310984098165067,0.00617868701822588,0.0183692636662965,7.93798051273923e-05
CR2,Complement receptor type 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29594,-0.000598658610491553,0.0031543145976074,-0.00678111522180206,0.00558379800081895,0.849474685781437
CR2,Complement receptor type 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29594,-0.00419267808035759,0.00317840550432841,-0.0104223528688413,0.00203699670812609,0.187141332084701
CR2,Complement receptor type 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29594,0.0073948521389452,0.00311499155129207,0.00128946869841275,0.0135002355794777,0.0176050048233583
CR2,Complement receptor type 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29594,0.0172840091610615,0.00318435827485458,0.0110426669423466,0.0235253513797765,5.7506050427467e-08
CR2,Complement receptor type 2,NMR metabolomics,X23523.Concentration of IDL Particles,29594,-0.00624542230058648,0.00309588985080394,-0.0123133664081622,-0.00017747819301075,0.0436704102587813
CR2,Complement receptor type 2,NMR metabolomics,X23524.Total Lipids in IDL,29594,-0.0212385828210458,0.00317248165295863,-0.0274566468608448,-0.0150205187812469,2.20084955293355e-11
CR2,Complement receptor type 2,NMR metabolomics,X23525.Phospholipids in IDL,29594,-0.015847999682711,0.00317707099573698,-0.0220750588343554,-0.00962094053106647,6.12760047693059e-07
CR2,Complement receptor type 2,NMR metabolomics,X23526.Cholesterol in IDL,29594,-0.0250615744476431,0.00318483799647641,-0.0313038569207369,-0.0188192919745494,3.69550364661268e-15
CR2,Complement receptor type 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29594,-0.0265879716518322,0.00318304552292416,-0.0328267408767636,-0.0203492024269009,6.942408298938e-17
CR2,Complement receptor type 2,NMR metabolomics,X23528.Free Cholesterol in IDL,29594,-0.0200781345237172,0.00318486599593977,-0.0263204718757592,-0.0138357971716753,2.93710043368914e-10
CR2,Complement receptor type 2,NMR metabolomics,X23529.Triglycerides in IDL,29594,0.00745580625238573,0.00315524963517112,0.00127151696745033,0.0136400955373211,0.0181348557092611
CR2,Complement receptor type 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,29594,-0.00061893315835579,0.00306295185820765,-0.00662231880044277,0.0053844524837312,0.839862758174052
CR2,Complement receptor type 2,NMR metabolomics,X23531.Total Lipids in Large LDL,29594,-0.0192018858928111,0.00308662390254786,-0.0252516687418049,-0.0131521030438173,5.00608762313518e-10
CR2,Complement receptor type 2,NMR metabolomics,X23532.Phospholipids in Large LDL,29594,-0.0182661398118512,0.00308354989480853,-0.024309897605676,-0.0122223820180265,3.1818188039231e-09
CR2,Complement receptor type 2,NMR metabolomics,X23533.Cholesterol in Large LDL,29594,-0.0205428122132513,0.00309413604619225,-0.0266073188637881,-0.0144783055627145,3.20685909664773e-11
CR2,Complement receptor type 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29594,-0.0191622144244516,0.00308360291174378,-0.0252060761314694,-0.0131183527174337,5.22645988998931e-10
CR2,Complement receptor type 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29594,-0.0239211432454601,0.00312953855142352,-0.0300550388062502,-0.01778724768467,2.17509157088718e-14
CR2,Complement receptor type 2,NMR metabolomics,X23536.Triglycerides in Large LDL,29594,0.000837900366781995,0.00315327681753164,-0.00534252219558003,0.00701832292914401,0.790453865260353
CR2,Complement receptor type 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29594,0.00512288671172809,0.00306183891442106,-0.000878317560537197,0.0111240909839934,0.0943102131946151
CR2,Complement receptor type 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,29594,-0.00671382722836052,0.00305903596075736,-0.0127095377114449,-0.000718116745276101,0.0281890914488303
CR2,Complement receptor type 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,29594,-0.00811859593496695,0.00305612955990647,-0.0141086098723836,-0.00212858199755027,0.00789997543383756
CR2,Complement receptor type 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,29594,-0.00735757904771124,0.0030572649591915,-0.0133498183677266,-0.0013653397276959,0.0161083872929876
CR2,Complement receptor type 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29594,-0.00388933337718235,0.00306561165360134,-0.00989793221824097,0.00211926546387627,0.204559012104654
CR2,Complement receptor type 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29594,-0.0163104236068184,0.00306285543621912,-0.0223136202618078,-0.0103072269518289,1.01557985664456e-07
CR2,Complement receptor type 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,29594,0.00746724049384883,0.00318301173354076,0.00122853749610894,0.0137059434915887,0.0189843534701916
CR2,Complement receptor type 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,29594,0.0110646853855773,0.00305923276744245,0.00506858916139008,0.0170607816097645,0.000298743918518821
CR2,Complement receptor type 2,NMR metabolomics,X23545.Total Lipids in Small LDL,29594,-0.00154809850667884,0.003056338008926,-0.0075385210041738,0.00444232399081612,0.612494928188951
CR2,Complement receptor type 2,NMR metabolomics,X23546.Phospholipids in Small LDL,29594,-0.00351288149726222,0.00305467230825191,-0.00950003922143597,0.00247427622691153,0.25015204365354
CR2,Complement receptor type 2,NMR metabolomics,X23547.Cholesterol in Small LDL,29594,-0.00315932023253539,0.00305479249553091,-0.00914671352377597,0.0028280730587052,0.301042892480437
CR2,Complement receptor type 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29594,0.000235353392536505,0.00306054867238981,-0.00576332200534752,0.00623402879042053,0.938704345538485
CR2,Complement receptor type 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29594,-0.0115935006614792,0.00306447923511832,-0.0175998799623111,-0.00558712136064728,0.00015513735669871
CR2,Complement receptor type 2,NMR metabolomics,X23550.Triglycerides in Small LDL,29594,0.0186065970995059,0.00321740705478801,0.0123004792721214,0.0249127149268904,7.40723900014772e-09
CR2,Complement receptor type 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29594,-0.0271502471917754,0.00359220145908089,-0.034190962051574,-0.0201095323319769,4.20798084559144e-14
CR2,Complement receptor type 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29594,-0.0270763870632324,0.00360800880669811,-0.0341480843243607,-0.0200046898021041,6.33850741045213e-14
CR2,Complement receptor type 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29594,-0.0250047949419186,0.00359933974147777,-0.0320595008352151,-0.0179500890486222,3.8071696391223e-12
CR2,Complement receptor type 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29594,-0.0320308533580426,0.00361352309525037,-0.0391133586247333,-0.0249483480913518,8.13102210021747e-19
CR2,Complement receptor type 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29594,-0.0379733925115047,0.00365115723710328,-0.0451296606962271,-0.0308171243267822,2.73068179447478e-25
CR2,Complement receptor type 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29594,-0.011345408994928,0.00343618488265521,-0.0180803313649322,-0.00461048662492376,0.000961989077455916
CR2,Complement receptor type 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29594,0.0123179550249862,0.00310870841872115,0.00622488652429279,0.0184110235256797,7.43732239073055e-05
CR2,Complement receptor type 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,29594,-0.060262628276829,0.00370298336934635,-0.0675204756807478,-0.0530047808729101,2.73032151262202e-59
CR2,Complement receptor type 2,NMR metabolomics,X23559.Total Lipids in Large HDL,29594,-0.0604457345408952,0.0036765993850811,-0.0676518693356542,-0.0532395997461362,1.81567177843832e-60
CR2,Complement receptor type 2,NMR metabolomics,X23560.Phospholipids in Large HDL,29594,-0.0607768690068067,0.00363425795528199,-0.0679000145991594,-0.053653723414454,1.71768767433356e-62
CR2,Complement receptor type 2,NMR metabolomics,X23561.Cholesterol in Large HDL,29594,-0.0613655141563909,0.00370081202233031,-0.0686191057201584,-0.0541119225926235,1.79373927653317e-61
CR2,Complement receptor type 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29594,-0.0624917742770914,0.00370015540199559,-0.0697440788650028,-0.0552394696891801,1.07948970956579e-63
CR2,Complement receptor type 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29594,-0.0556634072751753,0.00368267681865506,-0.0628814538397393,-0.0484453607106114,2.01007237646046e-51
CR2,Complement receptor type 2,NMR metabolomics,X23564.Triglycerides in Large HDL,29594,-0.00226276187958535,0.00318057587693141,-0.00849669059837091,0.0039711668392002,0.476822492491529
CR2,Complement receptor type 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29594,-0.071057930571265,0.00334523558045517,-0.0776145923089571,-0.0645012688335729,2.1847463904628e-99
CR2,Complement receptor type 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,29594,-0.0687610444994529,0.00330481981623013,-0.0752384913392639,-0.0622835976596418,1.83528764988958e-95
CR2,Complement receptor type 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,29594,-0.0642137481628994,0.00327006151379737,-0.0706230687299422,-0.0578044275958565,2.61985903070564e-85
CR2,Complement receptor type 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,29594,-0.0770695112993038,0.00336493872609354,-0.0836647912024471,-0.0704742313961604,4.28964405548826e-115
CR2,Complement receptor type 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29594,-0.077525428511418,0.00335322058583543,-0.0840977408596554,-0.0709531161631806,3.21881110247242e-117
CR2,Complement receptor type 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29594,-0.0724492726189906,0.00339746517193369,-0.0791083043559806,-0.0657902408820006,3.82260945629941e-100
CR2,Complement receptor type 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,29594,0.00353892134166229,0.00315422395106838,-0.00264335760243175,0.00972120028575632,0.261887444482217
CR2,Complement receptor type 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,29594,-0.0494397535131273,0.00305438493709504,-0.0554263479898336,-0.043453159036421,1.12323673381753e-58
CR2,Complement receptor type 2,NMR metabolomics,X23573.Total Lipids in Small HDL,29594,-0.0478194591240816,0.00307657577843382,-0.0538495476498119,-0.0417893705983513,2.90696700067484e-54
CR2,Complement receptor type 2,NMR metabolomics,X23574.Phospholipids in Small HDL,29594,-0.0489872538008057,0.00309082776286203,-0.0550452762160152,-0.0429292313855961,2.42860872271947e-56
CR2,Complement receptor type 2,NMR metabolomics,X23575.Cholesterol in Small HDL,29594,-0.0540007334340723,0.00305270817584199,-0.0599840414587226,-0.048017425409422,1.15617264378085e-69
CR2,Complement receptor type 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29594,-0.0529999341947383,0.00304477224765441,-0.0589676878001409,-0.0470321805893356,1.58976912889312e-67
CR2,Complement receptor type 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29594,-0.0495216511187913,0.0031050112463616,-0.0556074731616601,-0.0434358290759226,5.01218623177085e-57
CR2,Complement receptor type 2,NMR metabolomics,X23578.Triglycerides in Small HDL,29594,0.0195445997165345,0.00330140937946145,0.0130738373327901,0.026015362100279,3.25335406883851e-09
CR2,Complement receptor type 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28336,0.00327769702151936,0.00313873462755095,-0.0028742228484805,0.00942961689151921,0.296367837663314
CR2,Complement receptor type 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28336,-0.00893562048210021,0.00318247374888972,-0.015173269029924,-0.00269797193427636,0.00499215991660035
CR2,Complement receptor type 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28336,-0.00412687399709945,0.00315172903648888,-0.0103042629086177,0.00205051491441876,0.190409514016664
CR2,Complement receptor type 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28336,-0.0148846711403655,0.00321531704853231,-0.0211866925554889,-0.0085826497252422,3.68528393004273e-06
CR2,Complement receptor type 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28336,0.00507773949457084,0.0031388773800787,-0.0010744601703834,0.0112299391595251,0.10573994372453
CR2,Complement receptor type 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29280,0.0303641865395859,0.00306530640578261,0.024356185984252,0.0363721870949198,4.27295568020061e-23
CR2,Complement receptor type 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29280,-0.00622080610602733,0.00334984504390546,-0.012786502392082,0.000344890180027375,0.0633150838919177
CR2,Complement receptor type 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29280,-0.0108210269045029,0.00334454344456052,-0.0173763320558415,-0.00426572175316431,0.00121595735737074
CR2,Complement receptor type 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29280,0.0137271066922753,0.00324920638052415,0.00735866218644791,0.0200955511981026,2.39922261312817e-05
CR2,Complement receptor type 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29280,-0.00493187836702555,0.00326714352692058,-0.0113354796797899,0.00147172294573877,0.131172064547252
CR2,Complement receptor type 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29589,0.0342451411499276,0.00324450754007462,0.0278859063713813,0.0406043759284738,5.36894810178514e-26
CR2,Complement receptor type 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29589,0.00993797727377362,0.00315229098456813,0.00375948694402009,0.0161164676035272,0.00161973625832155
CR2,Complement receptor type 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29589,0.00482059210193904,0.0032678901328557,-0.00158447255845813,0.0112256567623362,0.140185828943496
CR2,Complement receptor type 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29589,0.0190002230175413,0.00308625954666294,0.0129511543060819,0.0250492917290007,7.537710763041e-10
CR2,Complement receptor type 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29589,-0.0210387985143224,0.00305520212203411,-0.0270269946735093,-0.0150506023551356,5.84384128211387e-12
CR2,Complement receptor type 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29594,-0.0060000980270257,0.00322496742906022,-0.0123210341879837,0.00032083813393233,0.062822712947717
CR2,Complement receptor type 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29594,-0.01384829,0.003363956,-0.02044164,-0.007254933,3.854322e-05
CR2,Complement receptor type 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29594,-0.0155367284107518,0.00338678501445407,-0.0221748270390818,-0.00889862978242182,4.50518432946149e-06
CR2,Complement receptor type 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29594,-0.0088843900027559,0.00328713837596678,-0.0153271812196508,-0.00244159878586102,0.00688028664063013
CR2,Complement receptor type 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29594,0.0121487008483955,0.00333738204618887,0.0056074320378653,0.0186899696589257,0.000272902344974651
CR2,Complement receptor type 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29594,-0.0203010828053345,0.00327505191412731,-0.026720184557024,-0.013881981053645,5.76806040516427e-10
CR2,Complement receptor type 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29594,-0.00322518897376164,0.00318126058279844,-0.00946045971604659,0.0030100817685233,0.310682437765739
CR2,Complement receptor type 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29594,0.00883904348084084,0.00310550916362096,0.00275224552014375,0.0149258414415379,0.00442684074387816
CR2,Complement receptor type 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29594,-0.0205307679367057,0.00329417258730096,-0.0269873462078156,-0.0140741896655958,4.65384299772234e-10
CR2,Complement receptor type 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29594,0.00828002976356653,0.0032119448905556,0.00198461777807754,0.0145754417490555,0.00994545310384922
CR2,Complement receptor type 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29594,0.037699239081394,0.00319501847216175,0.031437002875957,0.0439614752868311,4.6403370328865e-32
CR2,Complement receptor type 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29594,-0.0212937255322558,0.00334315712589529,-0.0278463134990105,-0.014741137565501,1.92622704153004e-10
CR2,Complement receptor type 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29594,-0.0243086842565955,0.00337527175382223,-0.0309242168940871,-0.017693151619104,6.07544890451013e-13
CR2,Complement receptor type 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29594,-2.31347141104912e-06,0.00310414123026809,-0.0060864302827365,0.0060818033399144,0.999405353296704
CR2,Complement receptor type 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29594,0.0151270173451817,0.00332170815514078,0.00861646936110574,0.0216375653292576,5.28482883627394e-06
CR2,Complement receptor type 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29594,0.0386388058455177,0.00304548733148924,0.0326696506757988,0.0446079610152366,8.6807209282659e-37
CR2,Complement receptor type 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29594,-0.0355863390357178,0.00320762212105892,-0.0418732783929933,-0.0292993996784423,1.52217751188928e-28
CR2,Complement receptor type 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29594,-0.041781717100701,0.00317876472983607,-0.0480120959711797,-0.0355513382302223,2.37509289884795e-39
CR2,Complement receptor type 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29594,-0.00419123716077177,0.00312908134163665,-0.0103242365903796,0.00194176226883606,0.180435639800241
CR2,Complement receptor type 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29594,0.0263302701777508,0.00327768189005089,0.019906013673251,0.0327545266822505,9.84669587085308e-16
CR2,Complement receptor type 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29594,0.0107182007989333,0.00307377933099689,0.00469359331017935,0.0167428082876872,0.000489220295459536
CR2,Complement receptor type 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29594,-0.028772359902968,0.00326313926163469,-0.035168112855772,-0.022376606950164,1.23453142230597e-18
CR2,Complement receptor type 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29594,-0.0123342994343749,0.00305697300019159,-0.0183259665147504,-0.00634263235399941,5.47842000948749e-05
CR2,Complement receptor type 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29594,-0.0283040369638859,0.00336957036398085,-0.0349083948772884,-0.0216996790504835,4.66603374164905e-17
CR2,Complement receptor type 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29594,0.0202219037265298,0.00322870624853851,0.0138936394793943,0.0265501679736652,3.82437798691588e-10
CR2,Complement receptor type 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29594,-0.0108499477094131,0.00308513858389745,-0.0168968193338521,-0.00480307608497412,0.000437366212462594
CR2,Complement receptor type 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29594,-0.00995412977689402,0.00311648137494232,-0.016062433271781,-0.00384582628200709,0.00140449360930662
CR2,Complement receptor type 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29594,0.0186433207970905,0.00314275601302285,0.0124835190115657,0.0248031225826153,3.02301995690493e-09
CR2,Complement receptor type 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29594,-0.031495323795252,0.00334260141970585,-0.0380468225778755,-0.0249438250126285,4.71910018646539e-21
CR2,Complement receptor type 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29594,0.0156541210720538,0.00316495351846429,0.00945081217586382,0.0218574299682438,7.61366431593946e-07
CR2,Complement receptor type 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29594,-0.00767717972081322,0.00309612232508588,-0.0137455794779815,-0.00160877996364489,0.0131580953569804
CR2,Complement receptor type 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29594,-0.0132823235890181,0.00308718062520971,-0.0193331976144291,-0.00723144956360704,1.69490412774326e-05
CR2,Complement receptor type 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29594,0.00921457843840275,0.00309359032522774,0.00315114140095639,0.0152780154758491,0.00289800259702835
CR2,Complement receptor type 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29594,-0.0234099535155537,0.00323068399826588,-0.0297420941521549,-0.0170778128789526,4.3933507851867e-13
CR2,Complement receptor type 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29594,0.0226316629293235,0.00324211025628932,0.0162771268269964,0.0289861990316506,3.00257762055876e-12
CR2,Complement receptor type 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29579,-0.0171248457086248,0.00346134132507185,-0.0239090747057656,-0.010340616711484,7.56008552390201e-07
CR2,Complement receptor type 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29579,-0.00508119262801666,0.00323015790657047,-0.0114123021248948,0.00124991686886147,0.115718462536734
CR2,Complement receptor type 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29579,-0.0384737142748335,0.00309359109455632,-0.0445371528201639,-0.0324102757295031,2.02895063344088e-35
CR2,Complement receptor type 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29579,0.0482069048328377,0.00363405814353492,0.0410841508715093,0.0553296587941661,4.78939512434729e-40
CR2,Complement receptor type 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29579,0.0313301644061928,0.00340708813418478,0.0246522716631906,0.0380080571491949,3.96726954387407e-20
CR2,Complement receptor type 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29594,0.00670087719404133,0.0033950591973574,4.65611672208341e-05,0.0133551932208618,0.0484235190208568
CR2,Complement receptor type 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29594,-0.0303120340349173,0.00347695901934871,-0.0371268737128407,-0.0234971943569938,2.97752182702036e-18
CR2,Complement receptor type 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29594,-0.0305829304188268,0.00342174022177407,-0.037289541253504,-0.0238763195841497,4.19404473331218e-19
CR2,Complement receptor type 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29594,-0.0122501954904345,0.00336338111919768,-0.0188424224840619,-0.00565796849680704,0.000270751678730281
CR2,Complement receptor type 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29594,0.0467550136669775,0.0033427941268524,0.0402031371783468,0.0533068901556083,2.59799923014712e-44
CR2,Complement receptor type 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29594,0.0521758243176467,0.00342227313143505,0.0454681689800341,0.0588834796552594,2.76940905882254e-52
CR2,Complement receptor type 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29594,-0.0521087776356335,0.00336614503256613,-0.0587064218994632,-0.0455111333718039,7.6733798219761e-54
CR2,Complement receptor type 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29594,-0.0425456384716067,0.00327750704778233,-0.0489695522852601,-0.0361217246579534,1.99484180561714e-38
CR2,Complement receptor type 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29594,-0.0617216366879958,0.00356824007608262,-0.0687153872371177,-0.0547278861388739,1.04681414297344e-66
CR2,Complement receptor type 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29594,0.0476285923251914,0.00329032568933083,0.041179553974103,0.0540776306762798,2.51838801236445e-47
CR2,Complement receptor type 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29594,-0.0126632761370817,0.0031580420544399,-0.0188530385637839,-0.00647351371037949,6.09062937617128e-05
CR2,Complement receptor type 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29594,-0.0216615032332481,0.00315282001363695,-0.0278410304599765,-0.0154819760065197,6.52359929443226e-12
CR2,Complement receptor type 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29594,-0.0200531472331069,0.00313212795750695,-0.0261921180298205,-0.0139141764363932,1.55241558288327e-10
CR2,Complement receptor type 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29594,-0.0087516060789341,0.00328547961556462,-0.0151911461254408,-0.00231206603242744,0.00773231486541844
CR2,Complement receptor type 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29594,0.0501077474516244,0.00334605291566885,0.0435494837369135,0.0566660111663354,1.63445701765241e-50
CR2,Complement receptor type 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50965,0.000632416661168755,0.00265481982659111,-0.00457103019894983,0.00583586352128734,0.811715664949286
CR2,Complement receptor type 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50965,0.0015225655022199,0.00259043615390995,-0.0035546893594436,0.00659982036388341,0.556693215600176
CR2,Complement receptor type 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47540,0.00172261538101797,0.00246695370930698,-0.00311261388922371,0.00655784465125964,0.485007815884893
CR2,Complement receptor type 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47540,0.00176694515646618,0.00268557936610545,-0.00349679040110051,0.00703068071403287,0.510581053110251
CR2,Complement receptor type 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47540,0.000533213760817056,0.00264814829523284,-0.00465715689783931,0.00572358441947342,0.840423083139699
CR2,Complement receptor type 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47540,-0.001926641430728,0.00243044924532272,-0.00669032195156053,0.00283703909010452,0.427950757460443
CR2,Complement receptor type 2,Working and living environment,X24009.Traffic intensity on the nearest road,50965,-0.0641468906259935,0.0348409743207666,-0.132435200294696,0.00414141904270901,0.0656077839629621
CR2,Complement receptor type 2,Working and living environment,X24010.Inverse distance to the nearest road,50965,0.000559462605035022,0.00231748250729623,-0.00398280310926559,0.00510172831933564,0.809238617757406
CR2,Complement receptor type 2,Working and living environment,X24011.Traffic intensity on the nearest major road,50965,0.00172998888749965,0.00231857709300047,-0.00281442221478127,0.00627439998978058,0.455584786230216
CR2,Complement receptor type 2,Working and living environment,X24012.Inverse distance to the nearest major road,50965,-0.000610502240575376,0.00235662894777355,-0.00522949497821154,0.00400849049706078,0.795591975657957
CR2,Complement receptor type 2,Working and living environment,X24013.Total traffic load on major roads,50965,-0.0219687350229198,0.0242425564126759,-0.0694841455917647,0.025546675545925,0.364831441910142
CR2,Complement receptor type 2,Working and living environment,X24015.Sum of road length of major roads within 100m,50965,-0.0334496030974091,0.0235649898778129,-0.0796369832579225,0.0127377770631042,0.155770542230693
CR2,Complement receptor type 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50965,0.00187650175268291,0.00265191156059625,-0.00332124490608574,0.00707424841145157,0.479194790276589
CR2,Complement receptor type 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50965,0.00167507822003299,0.00264860492435915,-0.00351618743171094,0.00686634387177691,0.527103592437603
CR2,Complement receptor type 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50965,0.00271196351365257,0.0026211169398681,-0.00242542568848891,0.00784935271579405,0.300832872054118
CR2,Complement receptor type 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50862,0.00257949698900401,0.00257368133715721,-0.00246491843182412,0.00762391240983213,0.316222968341577
CR2,Complement receptor type 2,Working and living environment,X24020.Average daytime sound level of noise pollution,50965,-0.00199983227810269,0.00232800057732097,-0.00656271340965178,0.00256304885344641,0.390325650159853
CR2,Complement receptor type 2,Working and living environment,X24021.Average evening sound level of noise pollution,50965,-0.00197328596868638,0.00232796288450842,-0.0065360932223229,0.00258952128495013,0.396639718119749
CR2,Complement receptor type 2,Working and living environment,X24022.Average night-time sound level of noise pollution,50965,-0.00199755754440455,0.00232801020663084,-0.00656045754940101,0.0025653424605919,0.390866901905612
CR2,Complement receptor type 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50965,-0.00196378549673644,0.00232791733125068,-0.00652650346598777,0.0025989324725149,0.39890786576259
CR2,Complement receptor type 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50965,-0.00196673820002704,0.00232792893499186,-0.00652947891261108,0.002596002512557,0.398201573895734
CR2,Complement receptor type 2,Health and medical history,X2405.Number of children fathered,23477,-0.0560906584981447,0.0266880484426468,-0.108399233445733,-0.00378208355055693,0.0355889257571528
CR2,Complement receptor type 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45479,-0.000115980401186053,0.0027212574763034,-0.00544964505474071,0.00521768425236861,0.96600452005345
CR2,Complement receptor type 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45479,0.00411780943752876,0.00246541465953468,-0.000714403295159205,0.00895002217021673,0.0948807573143992
CR2,Complement receptor type 2,Working and living environment,"X24502.Water percentage, buffer 1000m",45479,-0.00129314865524944,0.00245407547587451,-0.00610313658796349,0.00351683927746461,0.598238357042888
CR2,Complement receptor type 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45479,-0.000682575262513424,0.00256271904764455,-0.00570550459589675,0.0043403540708699,0.789972365945271
CR2,Complement receptor type 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45479,0.00303854790583843,0.00248720818711689,-0.00183638014091068,0.00791347595258753,0.221838737237495
CR2,Complement receptor type 2,Working and living environment,"X24505.Water percentage, buffer 300m",45479,-8.64002162825615e-05,0.00246603405843871,-0.00491982697082243,0.00474702653825731,0.972051108574703
CR2,Complement receptor type 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51197,-0.00232394124879868,0.0026109727431204,-0.00744144782531467,0.0027935653277173,0.373433976981649
CR2,Complement receptor type 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51197,-0.00424767198535525,0.00245407902423571,-0.00905766687285724,0.000562322902146743,0.0834824176838739
CR2,Complement receptor type 2,Working and living environment,X24508.Distance (Euclidean) to coast,51197,0.000264197604125309,0.00233110155550271,-0.00430476144466001,0.00483315665291062,0.90976466314232
CR2,Complement receptor type 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11254,-0.0401281041114714,0.0359194448464739,-0.11053021601056,0.0302740077876175,0.263945787033113
CR2,Complement receptor type 2,Health and medical history,X2704.Years since last cervical smear test,21143,0.0294843241563117,0.0259365225872102,-0.0213512601146203,0.0803199084272437,0.255639869387634
CR2,Complement receptor type 2,Health and medical history,X2714.Age when periods started (menarche),26972,-0.0316500536295752,0.0219205404683983,-0.0746143129476358,0.0113142056884854,0.148791751482856
CR2,Complement receptor type 2,Health and medical history,X2734.Number of live births,27807,-0.0457252641285099,0.0210249678617328,-0.0869342011375062,-0.00451632711951354,0.0296529278295572
CR2,Complement receptor type 2,Health and medical history,X2744.Birth weight of first child,22044,-0.0492942377350723,0.0234377345031435,-0.0952321973612337,-0.00335627810891098,0.0354596256931166
CR2,Complement receptor type 2,Health and medical history,X2754.Age at first live birth,18797,0.0109114015610868,0.00403120169636054,0.00301024623622013,0.0188125568859535,0.00680095258108284
CR2,Complement receptor type 2,Health and medical history,X2764.Age at last live birth,18742,0.00251443348211318,0.00388463738709759,-0.0050994557965981,0.0101283227608245,0.517461109279234
CR2,Complement receptor type 2,Health and medical history,X2794.Age started oral contraceptive pill,21333,0.0226979187247395,0.00437801861149855,0.0141170022462023,0.0312788352032766,2.18550310827667e-07
CR2,Complement receptor type 2,Health and medical history,X2804.Age when last used oral contraceptive pill,19343,-0.00949186540135135,0.00379378842566813,-0.0169276907156609,-0.00205604008704182,0.0123593655949445
CR2,Complement receptor type 2,Lifestyle factors,X2867.Age started smoking in former smokers,12614,0.000250930913590919,0.00482632825720282,-0.00920867247052662,0.00971053429770845,0.95853581696766
CR2,Complement receptor type 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19648,0.0471154469229131,0.0316630896721551,-0.014944208834511,0.109175102680337,0.136760546144446
CR2,Complement receptor type 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19639,0.0268309931229092,0.0349787021869776,-0.0417272631635669,0.0953892494093852,0.443051165082788
CR2,Complement receptor type 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19676,0.0278487103874301,0.0362365752638856,-0.0431749771297858,0.098872397904646,0.442184634585708
CR2,Complement receptor type 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19620,0.0643601142253166,0.0352726031265952,-0.00477418790281003,0.133494416353443,0.0680692506716201
CR2,Complement receptor type 2,Mental health,X28739.Difficulty with standing for long periods,19692,0.0430909113674494,0.0305269018136489,-0.0167418161873025,0.102923638922201,0.158091917055431
CR2,Complement receptor type 2,Mental health,X28740.Difficulty with taking care of household responsibilities,19738,0.0429846549452293,0.0340115257977383,-0.0236779356183379,0.109647245508796,0.206307379609375
CR2,Complement receptor type 2,Mental health,X28741.Difficulty learning a new task,19584,0.0584528109931453,0.0385740816619117,-0.0171523890642016,0.134058011050492,0.129702725417243
CR2,Complement receptor type 2,Mental health,X28742.Difficulty with joining in community activities,18875,0.0213921639256702,0.0389413810117823,-0.0549329428574231,0.0977172707087634,0.582776784292673
CR2,Complement receptor type 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19607,0.0448153374999527,0.0330775697231826,-0.0200166991574852,0.109647374157391,0.175479124910334
CR2,Complement receptor type 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19738,-0.0296694272046055,0.0470543733707346,-0.121895999011245,0.0625571446020343,0.528351946583961
CR2,Complement receptor type 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11970,0.0672014184058422,0.0341925834514653,0.000183954840970099,0.134218881970714,0.0493933916829075
CR2,Complement receptor type 2,Lifestyle factors,X2897.Age stopped smoking,12618,0.0161453703319512,0.00503043303447612,0.00628572158437803,0.0260050190795244,0.00133281028586189
CR2,Complement receptor type 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17619,0.00139541238418891,0.0081818284696821,-0.014640971416388,0.0174317961847658,0.864579427969936
CR2,Complement receptor type 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17619,0.00294604439976365,0.00890990655890223,-0.0145173724556847,0.020409461255212,0.740914182654524
CR2,Complement receptor type 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17619,-0.0219941279878629,0.0299149223656514,-0.0806273758245396,0.0366391198488139,0.462213711104868
CR2,Complement receptor type 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17619,-0.01514863809196,0.0304763932144315,-0.0748823687922457,0.0445850926083257,0.619151974349018
CR2,Complement receptor type 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17619,0.0135818747745633,0.034086904050169,-0.0532284571637679,0.0803922067128945,0.690304467210664
CR2,Complement receptor type 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17619,0.00453722486426368,0.0287613680705302,-0.0518350565539754,0.0609095062825028,0.874652346826682
CR2,Complement receptor type 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17619,-0.0101891693951491,0.0128851011271006,-0.0354439676042664,0.0150656288139681,0.429088057273867
CR2,Complement receptor type 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17619,0.0174427615767249,0.023208926603159,-0.0280467345654668,0.0629322577189166,0.452329362942576
CR2,Complement receptor type 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17501,-0.0154093894111961,0.0367889764217943,-0.0875157831979129,0.0566970043755206,0.675324416344021
CR2,Complement receptor type 2,Mental health,X29003.Recent feelings of depression,17483,0.027073938979941,0.0355726241456886,-0.0426484043456087,0.0967962823054907,0.446614083275873
CR2,Complement receptor type 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17508,0.0177888811911772,0.0287037412327024,-0.0384704516249194,0.0740482140072739,0.535436484522948
CR2,Complement receptor type 2,Mental health,X29005.Recent feelings of tiredness or low energy,17517,0.055836366673255,0.0287473195348059,-0.000508379614964645,0.112181112961475,0.052114928905472
CR2,Complement receptor type 2,Mental health,X29006.Recent poor appetite or overeating,17529,0.0407004677500543,0.0402062148543019,-0.0381037133643775,0.119504648864486,0.311411991033181
CR2,Complement receptor type 2,Mental health,X29007.Recent feelings of inadequacy,17462,0.0428661522557095,0.0387299767987862,-0.0330446022699114,0.11877690678133,0.268397746331695
CR2,Complement receptor type 2,Mental health,X29008.Recent trouble concentrating on things,17525,0.015686078244349,0.0382567689520819,-0.0592971889017315,0.0906693453904296,0.681795567306816
CR2,Complement receptor type 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17509,0.121451782455843,0.0670648748054986,-0.00999537216293454,0.25289893707462,0.0701642438765363
CR2,Complement receptor type 2,Mental health,X29010.Recent thoughts of suicide or self-harm,17424,0.113258807494518,0.0744967063223764,-0.0327547368973399,0.259272351886376,0.128448816239932
CR2,Complement receptor type 2,Mental health,X29038#0.Substances taken for depression_None of options listed,16138,0.0378696846014449,0.0161337004132248,0.00624763179152434,0.0694917374113655,0.0189250399517048
CR2,Complement receptor type 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16138,-0.0500022814812857,0.0314582418402567,-0.111660435488189,0.0116558725256175,0.111971418971288
CR2,Complement receptor type 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16138,-0.0153740433114299,0.0160322180459578,-0.0467971906815071,0.0160491040586473,0.337599952824724
CR2,Complement receptor type 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16138,-0.0172235771551478,0.0471853307360858,-0.109706825397876,0.0752596710875804,0.715101458573377
CR2,Complement receptor type 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16138,-0.027332208104319,0.0301425302152871,-0.0864115673262818,0.0317471511176437,0.364544339623862
CR2,Complement receptor type 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16138,-0.0732823522356962,0.0322662034944501,-0.136524111084818,-0.0100405933865741,0.023149214337532
CR2,Complement receptor type 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16138,0.0416598070533393,0.035878299135274,-0.0286616592517978,0.111981273358476,0.245601266626795
CR2,Complement receptor type 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16138,-0.008744822998639,0.0423708653197419,-0.0917917190253331,0.0743020730280551,0.836490728879515
CR2,Complement receptor type 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16138,-0.000946376509355209,0.0311859268947736,-0.0620707932231115,0.0601780402044011,0.975791272247631
CR2,Complement receptor type 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16138,0.0133177690749211,0.0158205168519449,-0.017690443954891,0.0443259821047331,0.399910344746351
CR2,Complement receptor type 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16138,0.00261125389314103,0.0245918637688587,-0.045588799093822,0.0508113068801041,0.915437962729189
CR2,Complement receptor type 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16138,-0.0537678284536833,0.0385073647078189,-0.129242263281008,0.0217066063736417,0.16264343357969
CR2,Complement receptor type 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16138,-0.067350569410778,0.0500693473380876,-0.16548649019343,0.0307853513718738,0.178597091786887
CR2,Complement receptor type 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16138,-0.0744450204326824,0.0309596295002013,-0.135125894253077,-0.0137641466122878,0.0162021004073611
CR2,Complement receptor type 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16138,-0.0474292719174804,0.0502878058895206,-0.145993371460941,0.05113482762598,0.34561498157345
CR2,Complement receptor type 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16138,-0.047519093459965,0.0487778018104717,-0.14312358500849,0.0480853980885596,0.329974312625398
CR2,Complement receptor type 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16138,-0.0377373367780004,0.0266200629388521,-0.0899126601381505,0.0144379865821497,0.156318832117299
CR2,Complement receptor type 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16138,-0.0118458110233147,0.0257621090015236,-0.062339544666301,0.0386479226196715,0.645655023794088
CR2,Complement receptor type 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16138,-0.0077455601769289,0.0368054040025647,-0.0798841520219557,0.0643930316680979,0.833322038062831
CR2,Complement receptor type 2,Mental health,X29058.Recent feelings or nervousness or anxiety,17246,0.106732715732783,0.0335279858643103,0.0410178634387347,0.172447568026831,0.0014581919373342
CR2,Complement receptor type 2,Mental health,X29059.Recent inability to stop or control worrying,17264,0.0588593363461829,0.0348681287656837,-0.00948219603455722,0.127200868726923,0.0914186553435389
CR2,Complement receptor type 2,Mental health,X29060.Recent worrying too much about different things,17255,0.0621807815313657,0.0321537425399723,-0.000840553846979987,0.125202116909711,0.0531469020564135
CR2,Complement receptor type 2,Mental health,X29061.Recent trouble relaxing,17257,0.0519723191563918,0.0340502260610809,-0.0147661239233267,0.11871076223611,0.12694284533477
CR2,Complement receptor type 2,Mental health,X29062.Recent restlessness,17278,-0.0214741333754697,0.0484292190736058,-0.116395402759737,0.0734471360087976,0.657472770041666
CR2,Complement receptor type 2,Mental health,X29063.Recent easy annoyance or irritability,17230,0.0294471010119523,0.0345767962347065,-0.0383234196080724,0.097217621631977,0.394423879727471
CR2,Complement receptor type 2,Mental health,X29064.Recent feelings of foreboding,17223,0.00977844725064358,0.0393404459869157,-0.0673288268837111,0.0868857213849983,0.803704394624478
CR2,Complement receptor type 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16138,0.0161117935978677,0.0169601853124657,-0.0171301696145651,0.0493537568103004,0.342137949162791
CR2,Complement receptor type 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16138,0.0122758182852695,0.0283980435591938,-0.0433843470907504,0.0679359836612893,0.665545953719138
CR2,Complement receptor type 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16138,0.014714246858811,0.0364906143160955,-0.0568073572007362,0.0862358509183582,0.686781628100209
CR2,Complement receptor type 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16138,0.0431298245035392,0.0384962536228694,-0.0323228325972848,0.118582481604363,0.262575280047866
CR2,Complement receptor type 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,16138,0.00457215973826111,0.0255252160408591,-0.0454572637018228,0.054601583178345,0.857843174424892
CR2,Complement receptor type 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16138,-0.00953490346372158,0.0274788045160481,-0.0633933603151758,0.0443235533877326,0.728602455374827
CR2,Complement receptor type 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16138,0.0229729968141913,0.027509698766979,-0.0309460127690875,0.0768920063974702,0.403680996397349
CR2,Complement receptor type 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16138,0.0168134029526519,0.0255040868364207,-0.0331746072467326,0.0668014131520365,0.509748845190603
CR2,Complement receptor type 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16138,0.0506458531766289,0.0339674145771136,-0.0159302793945138,0.117221985747772,0.135977671263843
CR2,Complement receptor type 2,Mental health,X29076.Felt loved as a child,17194,-0.0271063010949171,0.0298276574935387,-0.0855685097822529,0.0313559075924186,0.363487467470161
CR2,Complement receptor type 2,Mental health,X29077.Physically abused by family as a child,17219,0.0177635712001411,0.0402194334694371,-0.0610665183999557,0.0965936608002378,0.658736200223707
CR2,Complement receptor type 2,Mental health,X29078.Felt hated by family member as a child,17190,-0.018454712270408,0.0407167504309574,-0.0982595431150845,0.0613501185742684,0.65037719729363
CR2,Complement receptor type 2,Mental health,X29079.Sexually molested as a child,17065,-0.132227444639808,0.0541148046279838,-0.238292461710656,-0.0261624275689592,0.0145571899580969
CR2,Complement receptor type 2,Mental health,X29080.Someone to take to doctor when needed as a child,17163,-0.0543055603551658,0.0433298024806196,-0.13923197321718,0.0306208525068486,0.210110960972421
CR2,Complement receptor type 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17196,-0.0701209042520159,0.0562522499181632,-0.180375314091616,0.040133505587584,0.212581743234944
CR2,Complement receptor type 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17089,-0.0510992452638458,0.0440912292917935,-0.137518054675761,0.0353195641480694,0.246495408981009
CR2,Complement receptor type 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17209,-0.0936699595167792,0.0494672276355265,-0.190625725682411,0.00328580664885274,0.0582980714606051
CR2,Complement receptor type 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17159,-0.117745386128522,0.0688666912199602,-0.252724100919644,0.0172333286625999,0.0873287014508224
CR2,Complement receptor type 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17160,-0.0890707144310255,0.0659706377888882,-0.218373164497246,0.0402317356351955,0.176983469996712
CR2,Complement receptor type 2,Mental health,X29086.Experienced a violent or sexual assault,17210,-0.09398838997653,0.0558198535028188,-0.203395302842055,0.0154185228889949,0.0922422165778566
CR2,Complement receptor type 2,Mental health,X29087.Experienced a life-threatening injury or illness,17213,-0.0166361351241004,0.0348612149814046,-0.0849641164876535,0.0516918462394527,0.633218354268556
CR2,Complement receptor type 2,Mental health,X29088.Experienced a marital separation or divorce,17219,-0.0990843297100455,0.0325729453755511,-0.162927302646126,-0.0352413567739655,0.00235427595711068
CR2,Complement receptor type 2,Mental health,X29089.Experienced the death of a spouse or partner,17239,0.00858077396287352,0.0438191679706943,-0.0773047952596873,0.0944663431854344,0.844751498937339
CR2,Complement receptor type 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17214,0.0277728122221587,0.0408399479849121,-0.0522734858282689,0.107819110272586,0.496488069960078
CR2,Complement receptor type 2,Lifestyle factors,X29091.Frequency of drinking alcohol,17223,-0.276389914867723,0.0269823246700927,-0.329275271221105,-0.223504558514341,1.49084998919166e-24
CR2,Complement receptor type 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15351,-0.23143626533062,0.0312664211373803,-0.292718450759885,-0.170154079901354,1.41035296581069e-13
CR2,Complement receptor type 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15389,-0.269526952326671,0.0316132219243254,-0.331488867298349,-0.207565037354993,1.65765587144477e-17
CR2,Complement receptor type 2,Mental health,X29104.Ever used cannabis,17210,-0.0922318886193917,0.0390421054231312,-0.168754415248729,-0.0157093619900546,0.0181695963858418
CR2,Complement receptor type 2,Mental health,X29108.Ever thought that life not worth living,17129,0.0194115617239069,0.0341864849076961,-0.0475939486951774,0.0864170721429912,0.570168781239433
CR2,Complement receptor type 2,Mental health,X29109.Ever contemplated self-harm,17175,0.0264602219189873,0.0463783387206136,-0.0644413219734153,0.11736176581139,0.568325921521494
CR2,Complement receptor type 2,Mental health,X29111.Ever self-harmed,17200,0.0616602337749158,0.0745669565117206,-0.0844910009880565,0.207811468537888,0.408299010700706
CR2,Complement receptor type 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17193,-0.0283975044336203,0.0490111909745447,-0.124459438743728,0.0676644298764873,0.562321115994638
CR2,Complement receptor type 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17453,0.00884589256538758,0.0360333649872172,-0.0617795028095582,0.0794712879403333,0.806078611290193
CR2,Complement receptor type 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17453,-0.00647971296887596,0.0277552316286988,-0.0608799669611257,0.0479205410233738,0.815407621762631
CR2,Complement receptor type 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17453,-0.0102403805561292,0.0297332269325363,-0.0685175053439003,0.0480367442316419,0.730543137294459
CR2,Complement receptor type 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17453,0.0325728860888968,0.0402489303069136,-0.0463150173126539,0.111460789490448,0.418361837379679
CR2,Complement receptor type 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17176,-0.0571361138576725,0.0305069706839017,-0.11692977639812,0.00265754868277488,0.0611009550132298
CR2,Complement receptor type 2,Health and medical history,X29153.Pain or discomfort today,17202,0.0167018456276789,0.0286813540864442,-0.0395136083817517,0.0729172996371094,0.560355989688272
CR2,Complement receptor type 2,Mental health,X29154.Anxiety or depression today,17202,0.091663965858673,0.0360520133464421,0.0210020196996465,0.1623259120177,0.0110134518232214
CR2,Complement receptor type 2,Mental health,X29166.Frequency of confiding in someone close,16782,-0.0184575517682806,0.0281804386251828,-0.073691211473639,0.0367761079370778,0.512491260889296
CR2,Complement receptor type 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17150,0.0159898341171853,0.0083196805004008,-0.000316739663600272,0.0322964078979709,0.0546312720059706
CR2,Complement receptor type 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17150,-0.0249757758209253,0.00835121793868769,-0.0413441629807531,-0.00860738866109739,0.00278757512309789
CR2,Complement receptor type 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17150,-0.0353606583147978,0.010394814401924,-0.0557344945425689,-0.0149868220870267,0.000671064924292607
CR2,Complement receptor type 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17150,0.0337093622890204,0.0112503114406562,0.0116587518653342,0.0557599727127066,0.00273664185302914
CR2,Complement receptor type 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17150,-0.0401703373413522,0.0182225673491156,-0.0758865693456188,-0.00445410533708555,0.0275075008784644
CR2,Complement receptor type 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17150,-0.000529019866752464,0.00860084004445353,-0.0173866663538814,0.0163286266203765,0.950955416525339
CR2,Complement receptor type 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17147,0.0128294461387907,0.00935880804091632,-0.00551381762140531,0.0311727098989866,0.170442205200373
CR2,Complement receptor type 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17147,-0.031362654643377,0.0136960030936774,-0.0582068207069846,-0.00451848857976936,0.0220384615365862
CR2,Complement receptor type 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17147,-0.0486110233246358,0.0211359089866316,-0.0900374049384338,-0.00718464171083774,0.0214643832201553
CR2,Complement receptor type 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17147,0.0334228543921448,0.0189575626680018,-0.00373396843713877,0.0705796772214283,0.0779123408660976
CR2,Complement receptor type 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17147,-0.0537618632031361,0.0279857224811873,-0.108613879266263,0.00109015285999106,0.0547424695613049
CR2,Complement receptor type 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17147,0.00151672550104211,0.0134456299461535,-0.0248367091934187,0.0278701601955029,0.910186993825859
CR2,Complement receptor type 2,Mental health,X29171.Frequency of feeling 'in tune' with people,16856,-0.0576274680020223,0.0349175435202129,-0.126065853301639,0.0108109172975949,0.0988824082591738
CR2,Complement receptor type 2,Mental health,X29172.Freuency of feeling that lacks companionship,17081,0.0850485768490294,0.0318393442064441,0.022643462204399,0.14745369149366,0.00756571045257304
CR2,Complement receptor type 2,Mental health,X29173.Frequency of feeling left out,16989,0.0544312558809648,0.0331555625329669,-0.0105536466836503,0.11941615844558,0.100672162685714
CR2,Complement receptor type 2,Mental health,X29174.Frequency of feeling isolated from others,17057,0.018804058393349,0.0342012460363496,-0.0482303838378962,0.0858385006245943,0.582459485079181
CR2,Complement receptor type 2,Mental health,X29175.Tendency to bounce back quickly after hard times,17180,-0.0355092658483221,0.0283720590727809,-0.0911185016309726,0.0200999699343284,0.210748174216142
CR2,Complement receptor type 2,Mental health,X29176.Ability to make it through stressful events,17180,0.0623042829828077,0.0275692770021415,0.00826850005861033,0.116340065907005,0.0238388715081546
CR2,Complement receptor type 2,Mental health,X29177.Quick recovery from stressful events,17180,-0.0393124466895234,0.027998430495339,-0.0941893704603879,0.0155644770813411,0.16030875874469
CR2,Complement receptor type 2,Mental health,X29178.Hard to snap back when something bad happens,17180,0.0787666872810822,0.0275887780220674,0.0246926823578301,0.132840692204334,0.00430848448880717
CR2,Complement receptor type 2,Mental health,X29179.Comes through difficult times with little trouble,17180,-0.0435684738439859,0.0278939428227992,-0.0982406017766724,0.0111036540887006,0.118322176520268
CR2,Complement receptor type 2,Mental health,X29180.Tendency to take a long time to get over setbacks,17180,0.0605958646454395,0.0276869831649569,0.00632937764212402,0.114862351648755,0.0286390040289319
CR2,Complement receptor type 2,Mental health,X29181.General happiness,17082,0.0179420284495165,0.0287318424650196,-0.0383723827819219,0.074256439680955,0.53233063340904
CR2,Complement receptor type 2,Mental health,X29182.Belief that own life is meaningful,16885,-0.00389936437341877,0.0286070386235024,-0.0599691600754835,0.0521704313286459,0.891579532793181
CR2,Complement receptor type 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11480,0.0398070504852243,0.0325298756571609,-0.0239515058028111,0.10356560677326,0.22108776434954
CR2,Complement receptor type 2,Health and medical history,X2946.Father's age,11264,-0.0105599586463783,0.0072380776190205,-0.0247465907796585,0.00362667348690187,0.144608108028001
CR2,Complement receptor type 2,Health and medical history,X2966.Age high blood pressure diagnosed,12894,-0.0121170902773771,0.00591095913468153,-0.0237025701813529,-0.000531610373401279,0.040390840505052
CR2,Complement receptor type 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50008,0.000665950209431501,0.00246746786317293,-0.00417028680238744,0.00550218722125044,0.787244339639816
CR2,Complement receptor type 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50009,0.070367270823628,0.00273811007353652,0.0650005750794964,0.0757339665677595,1.04338505710491e-144
CR2,Complement receptor type 2,Blood and urine assays,X30020.Haemoglobin concentration,50009,0.0372407530056906,0.00294196045182561,0.0314745105201124,0.0430069954912688,1.14331379699224e-36
CR2,Complement receptor type 2,Blood and urine assays,X30030.Haematocrit percentage,50009,0.0356574734711783,0.00287532127719754,0.0300218437678711,0.0412931031744855,2.90084018644987e-35
CR2,Complement receptor type 2,Blood and urine assays,X30040.Mean corpuscular volume,50009,-0.0595953615143845,0.00242109061545914,-0.0643406991206844,-0.0548500239080846,5.41301980376812e-133
CR2,Complement receptor type 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50008,-0.0520220584327627,0.00243140982166975,-0.0567876216832354,-0.0472564951822899,4.15814984618247e-101
CR2,Complement receptor type 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50008,0.00103697100952374,0.00238489263764896,-0.00363741856026822,0.00571136057931569,0.663703488197505
CR2,Complement receptor type 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50009,-0.000499605288772892,0.00238027048165975,-0.00516493543282599,0.00416572485528021,0.833750999408726
CR2,Complement receptor type 2,Blood and urine assays,X30080.Platelet count,50009,-0.041841267789038,0.0024284663995656,-0.0466010619321866,-0.0370814736458895,2.48149907332643e-66
CR2,Complement receptor type 2,Blood and urine assays,X30090.Platelet crit,50009,-0.0387068648599631,0.00248187734067152,-0.0435713444476792,-0.0338423852722469,1.04657855060966e-54
CR2,Complement receptor type 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50009,0.0168376769509526,0.00233726592838544,0.0122566357313172,0.0214187181705881,5.92916821849049e-13
CR2,Complement receptor type 2,Blood and urine assays,X30110.Platelet distribution width,50009,0.0337023576953585,0.00236037253597955,0.0290760275248385,0.0383286878658784,3.67809760575594e-46
CR2,Complement receptor type 2,Blood and urine assays,X30120.Lymphocyte count,49933,0.00643067767587654,0.00242935460667787,0.00166914264678791,0.0111922127049652,0.00812174412946806
CR2,Complement receptor type 2,Blood and urine assays,X30130.Monocyte count,49933,-0.00354053170393519,0.0024511025331575,-0.00834469266892389,0.0012636292610535,0.148614507879999
CR2,Complement receptor type 2,Blood and urine assays,X30140.Neutrophill count,49933,-0.00456735682473015,0.00244122146126267,-0.00935215088880498,0.00021743723934469,0.0613604958958089
CR2,Complement receptor type 2,Blood and urine assays,X30150.Eosinophill count,49933,0.0294024566900191,0.00237117343416849,0.0247549567590488,0.0340499566209893,2.94696206145444e-35
CR2,Complement receptor type 2,Blood and urine assays,X30160.Basophill count,49933,-0.03248920902753,0.0175464327763838,-0.0668802172692423,0.00190179921418233,0.0640872671003673
CR2,Complement receptor type 2,Blood and urine assays,X30170.Nucleated red blood cell count,49933,0.0646005634414195,0.08117642428923,-0.0945052281654713,0.22370635504831,0.426149462139917
CR2,Complement receptor type 2,Blood and urine assays,X30180.Lymphocyte percentage,49934,0.00685792159253986,0.00239337557096762,0.00216690547344333,0.0115489377116364,0.0041668787122005
CR2,Complement receptor type 2,Blood and urine assays,X30190.Monocyte percentage,49934,-0.00541327106194353,0.00242285821707342,-0.0101620731674074,-0.000664468956479618,0.0254710347426808
CR2,Complement receptor type 2,Blood and urine assays,X30200.Neutrophill percentage,49934,-0.00938682410633269,0.00236914404891981,-0.0140303464422155,-0.00474330177044985,7.43915273790097e-05
CR2,Complement receptor type 2,Blood and urine assays,X30210.Eosinophill percentage,49934,0.0294836393530119,0.00234729131763887,0.0248829483704397,0.0340843303355841,3.93827288059748e-36
CR2,Complement receptor type 2,Blood and urine assays,X30220.Basophill percentage,49934,-0.00892286799548872,0.00233983949310874,-0.0135089534019819,-0.00433678258899558,0.000137203312366849
CR2,Complement receptor type 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,49932,0.0620873881350984,0.081266958091376,-0.0971958497239986,0.221370625994195,0.444875017719824
CR2,Complement receptor type 2,Blood and urine assays,X30240.Reticulocyte percentage,49138,0.0135808324519707,0.00252001367078876,0.00864160565722476,0.0185200592467167,7.11010389310327e-08
CR2,Complement receptor type 2,Blood and urine assays,X30250.Reticulocyte count,49138,0.0276460072510177,0.00257164188558452,0.022605589155272,0.0326864253467633,6.32683560432326e-27
CR2,Complement receptor type 2,Blood and urine assays,X30260.Mean reticulocyte volume,49138,-0.0311688267752001,0.00239916944831571,-0.0358711988938989,-0.0264664546565013,1.5825384099296e-38
CR2,Complement receptor type 2,Blood and urine assays,X30270.Mean sphered cell volume,49138,-0.0573957290286584,0.00241013357725187,-0.0621195908400721,-0.0526718672172447,1.21106074992469e-124
CR2,Complement receptor type 2,Blood and urine assays,X30280.Immature reticulocyte fraction,49138,-0.00881796820505935,0.0025188421661108,-0.0137548988506365,-0.00388103755948219,0.00046427113660896
CR2,Complement receptor type 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49138,0.00663998306118515,0.00257439492596248,0.0015941690062987,0.0116857971160716,0.00990466854306564
CR2,Complement receptor type 2,Blood and urine assays,X30300.High light scatter reticulocyte count,49138,0.0178306289924192,0.00261223057671667,0.0127106570620545,0.0229506009227838,8.84334520095997e-12
CR2,Complement receptor type 2,Blood and urine assays,X30500.Microalbumin in urine,16249,0.0174755964448858,0.00426989834694024,0.00910659568488295,0.0258445972048887,4.28361164027993e-05
CR2,Complement receptor type 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50119,-0.0113170623548706,0.00254522800820097,-0.0163057092509445,-0.00632841545879671,8.75149690950994e-06
CR2,Complement receptor type 2,Blood and urine assays,X30520.Potassium in urine,50019,-0.00912343714112911,0.00237004488197521,-0.0137687251098005,-0.0044781491724577,0.000118516678902298
CR2,Complement receptor type 2,Blood and urine assays,X30530.Sodium in urine,50002,-0.00751590180103899,0.00247826192390541,-0.0123732951718936,-0.00265850843018438,0.00242475739349085
CR2,Complement receptor type 2,Blood and urine assays,X30600.Albumin,45095,0.0354562872038115,0.00254517072715338,0.0304677525785909,0.0404448218290321,5.08068353545828e-44
CR2,Complement receptor type 2,Blood and urine assays,X30610.Alkaline phosphatase,49203,0.0673223222059467,0.0024306867570633,0.0625581761621026,0.0720864682497908,1.48273388440392e-167
CR2,Complement receptor type 2,Blood and urine assays,X30620.Alanine aminotransferase,49196,0.0392789107919124,0.00258445941326739,0.0342133703419083,0.0443444512419164,4.78040787593356e-52
CR2,Complement receptor type 2,Blood and urine assays,X30630.Apolipoprotein A,44812,-0.0739640349461964,0.00277617348206048,-0.079405334971035,-0.0685227349213579,3.56600197115754e-155
CR2,Complement receptor type 2,Blood and urine assays,X30640.Apolipoprotein B,48940,-0.00687956380359003,0.00236967713495774,-0.0115241309881072,-0.00223499661907285,0.00369576917246726
CR2,Complement receptor type 2,Blood and urine assays,X30650.Aspartate aminotransferase,49049,0.034787191891203,0.00245584726076495,0.0299737312601037,0.0396006525223023,1.85391240426589e-45
CR2,Complement receptor type 2,Blood and urine assays,X30660.Direct bilirubin,41759,0.0140041850785246,0.00266512999924453,0.00878053028000534,0.0192278398770439,1.49075776403527e-07
CR2,Complement receptor type 2,Blood and urine assays,X30670.Urea,49181,0.0308998150557096,0.00249662847629289,0.0260064232421755,0.0357932068692436,3.94614143894815e-35
CR2,Complement receptor type 2,Blood and urine assays,X30680.Calcium,45091,0.024649870677064,0.00247042977401783,0.0198078283199891,0.029491913034139,2.01283613651736e-23
CR2,Complement receptor type 2,Blood and urine assays,X30690.Cholesterol,49215,-0.0199096875805587,0.00240344323838717,-0.0246204363277975,-0.0151989388333198,1.22257864175525e-16
CR2,Complement receptor type 2,Blood and urine assays,X30700.Creatinine,49196,0.0346516941716144,0.00289533322539225,0.0289768410498456,0.0403265472933832,5.80082345613773e-33
CR2,Complement receptor type 2,Blood and urine assays,X30710.C-reactive protein,49067,-0.00586386334867519,0.00265466499982149,-0.0110670067483253,-0.000660719949025081,0.027186887858024
CR2,Complement receptor type 2,Blood and urine assays,X30720.Cystatin C,49216,0.0761206830821116,0.00274989135704998,0.0707308960222936,0.0815104701419296,2.26138670943075e-167
CR2,Complement receptor type 2,Blood and urine assays,X30730.Gamma glutamyltransferase,49194,0.0137664385238975,0.00264071795438408,0.00859063133330466,0.0189422457144902,1.86417236011066e-07
CR2,Complement receptor type 2,Blood and urine assays,X30740.Glucose,45040,0.0107133469920611,0.00254381975773636,0.00572746026689786,0.0156992337172244,2.54150871695826e-05
CR2,Complement receptor type 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48903,0.0267675999487528,0.00257205671812959,0.0217263687812188,0.0318088311162868,2.44650973491358e-25
CR2,Complement receptor type 2,Blood and urine assays,X30760.HDL cholesterol,45064,-0.0781732006109171,0.00289742636883906,-0.0838521562938417,-0.0724942449279926,4.66405142865711e-159
CR2,Complement receptor type 2,Blood and urine assays,X30770.IGF-1,48956,0.0245707778704801,0.00247520289391377,0.0197193801984091,0.0294221755425511,3.34895925749358e-23
CR2,Complement receptor type 2,Blood and urine assays,X30780.LDL direct,49104,-0.00667957804959927,0.00237270133925324,-0.0113300726745356,-0.00202908342466292,0.00487695455854587
CR2,Complement receptor type 2,Blood and urine assays,X30790.Lipoprotein A,39333,-0.0027222183142556,0.00264047108098982,-0.00789754163299564,0.00245310500448444,0.30256623046086
CR2,Complement receptor type 2,Blood and urine assays,X30810.Phosphate,44989,0.0144569014123938,0.00256108626987226,0.00943717232344414,0.0194766305013434,1.66336257558634e-08
CR2,Complement receptor type 2,Blood and urine assays,X30830.SHBG,44671,-0.0227932957117993,0.00294240635502075,-0.02856041216764,-0.0170261792559586,9.6460295317785e-15
CR2,Complement receptor type 2,Blood and urine assays,X30840.Total bilirubin,49020,0.0216641210200802,0.00251606808256477,0.0167326275782533,0.0265956144619072,7.49907452457958e-18
CR2,Complement receptor type 2,Blood and urine assays,X30850.Testosterone,44452,-0.0233183862796723,0.00410240174362674,-0.0313590936971807,-0.0152776788621639,1.32339199198499e-08
CR2,Complement receptor type 2,Blood and urine assays,X30860.Total protein,45059,0.0314708532517524,0.00250500392515569,0.0265610455584473,0.0363806609450576,3.86903859122558e-36
CR2,Complement receptor type 2,Blood and urine assays,X30870.Triglycerides,49179,0.0233812965505069,0.00257767862408128,0.0183290464473076,0.0284335466537063,1.22516531975417e-19
CR2,Complement receptor type 2,Blood and urine assays,X30880.Urate,49144,0.0238335602765393,0.00296510554055343,0.0180219534170545,0.029645167136024,9.33254779935732e-16
CR2,Complement receptor type 2,Blood and urine assays,X30890.Vitamin D,46975,-0.00345386929543517,0.00267711012321069,-0.00870100513692812,0.00179326654605778,0.197005496584673
CR2,Complement receptor type 2,Physical measures,X3137.Number of measurements made,46757,0.0176416233031447,0.0204126014728055,-0.0223670755835541,0.0576503221898435,0.387454131687518
CR2,Complement receptor type 2,Physical measures,X3143.Ankle spacing width,29284,0.0187045945557847,0.00419749987572118,0.0104774947993712,0.0269316943121983,8.3762711100006e-06
CR2,Complement receptor type 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29282,-0.00761401195449257,0.00323542815793916,-0.0139554511440533,-0.0012725727649318,0.0186129723093815
CR2,Complement receptor type 2,Physical measures,X3146.Speed of sound through heel,29284,-0.00709415565305829,0.00312500306151778,-0.0132191616536331,-0.000969149652483441,0.0232070805124619
CR2,Complement receptor type 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29284,-0.00766081683734887,0.00315775684052754,-0.0138500202447828,-0.00147161342991489,0.0152709567293823
CR2,Complement receptor type 2,Physical measures,X3148.Heel bone mineral density (BMD),29262,-0.00835890566957051,0.00316250333603874,-0.0145574122082064,-0.00216039913093459,0.00821874051115081
CR2,Complement receptor type 2,Health and medical history,X3526.Mother's age at death,30762,-0.002124588,0.003164159,-0.00832634,0.004077163,0.5019362
CR2,Complement receptor type 2,Health and medical history,X3581.Age at menopause (last menstrual period),15890,0.00623032470106615,0.00424142252998278,-0.00208286345770011,0.0145435128598324,0.141873385777958
CR2,Complement receptor type 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10150,0.0094786767561244,0.00534945509326235,-0.00100625522666981,0.0199636087389186,0.0764419005894697
CR2,Complement receptor type 2,Physical measures,X4100.Ankle spacing width (left),16572,0.016091675600301,0.00567827689058306,0.00496225289475822,0.0272210983058438,0.00460391663251934
CR2,Complement receptor type 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16568,-0.00259994613096646,0.00437727615062772,-0.0111794073861968,0.00597951512426388,0.552544051146486
CR2,Complement receptor type 2,Physical measures,X4103.Speed of sound through heel (left),16572,-0.00071364974207902,0.0042335206680182,-0.0090113502513947,0.00758405076723666,0.866135978980943
CR2,Complement receptor type 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16572,-0.00156365275581558,0.00427817125305141,-0.00994886841179634,0.00682156290016518,0.714746161691586
CR2,Complement receptor type 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16560,-0.00139228944175258,0.00428246698207487,-0.00978592472661931,0.00700134584311416,0.745098997581716
CR2,Complement receptor type 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16572,-0.00155717462884381,0.00427818228546364,-0.00994241190835255,0.00682806265066492,0.715877270346759
CR2,Complement receptor type 2,Physical measures,X4119.Ankle spacing width (right),16562,0.0149389361429993,0.00559371220874597,0.00397526021385723,0.0259026120721414,0.00757749727353753
CR2,Complement receptor type 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16561,-0.00430898870248529,0.00438896487439246,-0.0129113598562945,0.00429338245132393,0.326223633912114
CR2,Complement receptor type 2,Physical measures,X4122.Speed of sound through heel (right),16562,-0.000267918900474952,0.00423510986448998,-0.00856873423487531,0.00803289643392541,0.949559131378218
CR2,Complement receptor type 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16562,-0.00181007561297312,0.00428314510804085,-0.0102050400247332,0.00658488879878695,0.672589467348451
CR2,Complement receptor type 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16547,-0.00270550557966199,0.00429015982459343,-0.0111142188358651,0.00570320767654113,0.528290876681683
CR2,Complement receptor type 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16562,-0.00180798791847753,0.00428315016150018,-0.0102029622350179,0.00658698639806281,0.672945543203074
CR2,Complement receptor type 2,Physical measures,X4194.Pulse rate,17210,0.00407198703870504,0.00408709016174441,-0.00393870967831401,0.0120826837557241,0.319116151639233
CR2,Complement receptor type 2,Physical measures,X4195.Pulse wave reflection index,17210,-0.00432020191842814,0.00418789214162631,-0.0125284705160157,0.00388806667915943,0.302277139077568
CR2,Complement receptor type 2,Physical measures,X4196.Pulse wave peak to peak time,17200,-0.00495029149108498,0.00417182534144593,-0.013127069160319,0.00322648617814905,0.235401503673757
CR2,Complement receptor type 2,Physical measures,X4198.Position of the pulse wave peak,17210,0.00394550669272847,0.00421090123226252,-0.00430785972250607,0.012198873107963,0.348784880606293
CR2,Complement receptor type 2,Physical measures,X4199.Position of pulse wave notch,17210,0.00512804575420474,0.0040896583782912,-0.00288768466724602,0.0131437761756555,0.209893346158201
CR2,Complement receptor type 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,17210,0.00548213739601816,0.00423528412418633,-0.00281901948738705,0.0137832942794234,0.19554584398592
CR2,Complement receptor type 2,Physical measures,X4269.Number of triplets attempted (left),16893,0.0350356545595219,0.0850522535709201,-0.131666762439482,0.201738071558525,0.68039527920337
CR2,Complement receptor type 2,Physical measures,X4270.Volume level set by participant (left),16715,-0.00975045442878534,0.027060776518275,-0.0627895764046044,0.0432886675470337,0.718614738675095
CR2,Complement receptor type 2,Physical measures,X4276.Number of triplets attempted (right),16893,0.0531922471770251,0.0827942134114128,-0.109084411109344,0.215468905463394,0.520581115395452
CR2,Complement receptor type 2,Physical measures,X4277.Volume level set by participant (right),16695,0.0167216668897449,0.0268304466174842,-0.0358660084805241,0.0693093422600138,0.533138786615076
CR2,Complement receptor type 2,Cognitive function,X4288.Time to answer,17245,-0.00258245765625772,0.00474271641777024,-0.0118781818350874,0.00671326652257195,0.586097449829648
CR2,Complement receptor type 2,Cognitive function,X4290.Duration screen displayed,17245,0.00847366584254263,0.00431420910682604,1.78159931635991e-05,0.0169295156919217,0.0495311135060157
CR2,Complement receptor type 2,Physical measures,X46.Hand grip strength (left),51443,-0.013806506155405,0.00334561736533937,-0.0203639161914702,-0.00724909611933985,3.68514465082346e-05
CR2,Complement receptor type 2,Physical measures,X47.Hand grip strength (right),51451,-0.01336794214695,0.00331954326613562,-0.0198742469485758,-0.00686163734532421,5.65637636872757e-05
CR2,Complement receptor type 2,Physical measures,X48.Waist circumference,51591,0.01542788,0.005162393,0.005309591,0.02554617,0.002804702
CR2,Complement receptor type 2,Health and medical history,X4803.Tinnitus,16937,0.0707733763645885,0.0315293569023935,0.00897583683589732,0.13257091589328,0.0248014288377956
CR2,Complement receptor type 2,Working and living environment,X4825.Noisy workplace,17155,-0.0433772493285508,0.0358239571580377,-0.113592205358305,0.0268377067012031,0.225971619293658
CR2,Complement receptor type 2,Working and living environment,X4836.Loud music exposure frequency,17047,-0.0689666681703699,0.0460329434197706,-0.15919123727312,0.0212579009323804,0.134099195272775
CR2,Complement receptor type 2,Physical measures,X49.Hip circumference,51582,0.00512113764551762,0.00413405238072222,-0.00298160502069794,0.0132238803117332,0.215436542430362
CR2,Complement receptor type 2,Physical measures,X50.Standing height,51537,0.0177929475857713,0.00328315951746248,0.0113579549315448,0.0242279402399977,6.00472646440526e-08
CR2,Complement receptor type 2,Health and medical history,X5057.Number of older siblings,15135,-0.028974628764637,0.028710962700084,-0.0852481156568017,0.0272988581275277,0.312902805380666
CR2,Complement receptor type 2,Physical measures,X51.Seated height,51306,0.0150893163804488,0.00305128845474395,0.00910879100915066,0.0210698417517469,7.6294742473796e-07
CR2,Complement receptor type 2,Eye measures,X5181.Ever had eye surgery,11608,0.0527949220099023,0.0650327229032709,-0.0746692148805085,0.180259058900313,0.416911091538654
CR2,Complement receptor type 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11579,0.00386792255956687,0.00498966838017139,-0.00591182746556905,0.0136476725847028,0.438245433015115
CR2,Complement receptor type 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11578,0.00486311124826229,0.00503029472632091,-0.00499626641532669,0.0147224889118513,0.333681904732323
CR2,Complement receptor type 2,Eye measures,X5190.Duration at which refractometer first shown (right),11452,0.00684189684281904,0.00504868339097933,-0.00305352260350045,0.0167373162891385,0.175385583209712
CR2,Complement receptor type 2,Eye measures,X5193.Duration at which refractometer first shown (left),11450,0.00229283263561654,0.00508094213896218,-0.00766581395674932,0.0122514792279824,0.651809778765058
CR2,Complement receptor type 2,Eye measures,"X5199.logMAR, initial (right)",11539,-0.0405372315675169,0.0341893063373592,-0.107548271988741,0.0264738088537072,0.235777131154757
CR2,Complement receptor type 2,Eye measures,X5200.Final number of letters displayed (right),11539,-0.21640410821905,0.224034258121364,-0.655511254136923,0.222703037698823,0.334093456322824
CR2,Complement receptor type 2,Eye measures,"X5201.logMAR, final (right)",11426,-0.00965257640033542,0.00507729121193595,-0.0196040671757299,0.00029891437505904,0.0573105201745258
CR2,Complement receptor type 2,Eye measures,X5202.Number of rounds to result (right),11539,-0.00489775528289345,0.0321474326815872,-0.0679067233388044,0.0581112127730175,0.878911256313948
CR2,Complement receptor type 2,Eye measures,"X5206.logMAR, initial (left)",11533,-8.56614255454372e-06,0.0340760449703226,-0.0667976142843868,0.0667804819992777,0.999799429644044
CR2,Complement receptor type 2,Eye measures,X5207.Final number of letters displayed (left),11533,-0.0870817419553351,0.202471152682046,-0.483925201212146,0.309761717301475,0.667134901967642
CR2,Complement receptor type 2,Eye measures,"X5208.logMAR, final (left)",11422,-0.0012960740097272,0.0050729250502494,-0.011239007108216,0.00864685908876162,0.798350430938108
CR2,Complement receptor type 2,Eye measures,X5209.Number of rounds to result (left),11527,-0.0103094590110931,0.0321990788197355,-0.0734196534977747,0.0528007354755885,0.748838689218835
CR2,Complement receptor type 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11037,0.00591373362482939,0.00499766478817747,-0.00388168935999846,0.0157091566096572,0.236716038986443
CR2,Complement receptor type 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11037,0.00526620488538406,0.00496856281430969,-0.00447217823066293,0.015004588001431,0.289211015217646
CR2,Complement receptor type 2,Eye measures,X5256.Corneal hysteresis (right),11037,0.000448652130739444,0.00503982740404982,-0.0094294095811982,0.0103267138426771,0.92906657699809
CR2,Complement receptor type 2,Eye measures,X5257.Corneal resistance factor (right),11037,0.00394559570588831,0.00500907892125399,-0.00587219897976951,0.0137633903915461,0.430895655394287
CR2,Complement receptor type 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11009,0.00717566742729448,0.00501896401185645,-0.00266150203594417,0.0170128368905331,0.152828430641927
CR2,Complement receptor type 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11009,0.00956108705385041,0.00497892665043946,-0.00019760918101093,0.0193197832887117,0.0548444804868014
CR2,Complement receptor type 2,Eye measures,X5264.Corneal hysteresis (left),11009,0.00258191212103414,0.00505330318599807,-0.00732256212352208,0.0124863863655904,0.609406462626941
CR2,Complement receptor type 2,Eye measures,X5265.Corneal resistance factor (left),11009,0.00652453501319722,0.00500750642433883,-0.00329017757850689,0.0163392476049013,0.192618810587274
CR2,Complement receptor type 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11528,0.0292513912254632,0.151505692715557,-0.267699766497028,0.326202548947955,0.846906585498882
CR2,Complement receptor type 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51431,0.00992917887583844,0.0133256080827102,-0.0161890129662735,0.0360473707179503,0.456202504556832
CR2,Complement receptor type 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51431,0.0182648592270433,0.0145341091033914,-0.0102219946156039,0.0467517130696904,0.208871877377644
CR2,Complement receptor type 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51431,0.0146431076923163,0.013878237382729,-0.0125582375778325,0.0418444529624651,0.291378637396575
CR2,Complement receptor type 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51431,0.00437824565951871,0.00594244302216934,-0.00726894266393319,0.0160254339829706,0.461262324969104
CR2,Complement receptor type 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51431,-0.00611328107197188,0.00546749713869516,-0.0168295754638144,0.00460301331987063,0.2635238461112
CR2,Complement receptor type 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23251,-0.00527913144454255,0.00700971913869757,-0.0190181809563898,0.00845991806730469,0.451387857011897
CR2,Complement receptor type 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23251,0.00124356320762623,0.0190553776949433,-0.0361049770744626,0.0385921034897151,0.947967164315261
CR2,Complement receptor type 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23251,-0.0493236782882262,0.0136364765807258,-0.0760511723864488,-0.0225961841900036,0.000298622644887763
CR2,Complement receptor type 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23251,-0.00225091541436922,0.00829641777839503,-0.0185118942600235,0.014010063431285,0.786153699787259
CR2,Complement receptor type 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51586,0.000998871295433257,0.00917572282248164,-0.0169855454366308,0.0189832880274973,0.913313774630035
CR2,Complement receptor type 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51586,-0.0059482168056298,0.0117639302699638,-0.0290055201347588,0.0171090865234992,0.61311734015696
CR2,Complement receptor type 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51586,-0.00106985946848917,0.00906536187412265,-0.0188379687417696,0.0166982498047912,0.90605528945107
CR2,Complement receptor type 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51586,0.0143011331747391,0.014959044034862,-0.0150185931335904,0.0436208594830687,0.339067020191116
CR2,Complement receptor type 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51586,0.0755430169210128,0.0359348903950949,0.00511063174662682,0.145975402095399,0.0355389133513486
CR2,Complement receptor type 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51586,0.0284242000995449,0.0249667343847712,-0.0205105992946066,0.0773589994936964,0.254924184900316
CR2,Complement receptor type 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51586,-0.041095853973085,0.039088167520749,-0.117708662313753,0.035516954367583,0.293096818077179
CR2,Complement receptor type 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51430,-0.00596276619320511,0.00759102001870325,-0.0208411654298635,0.00891563304345325,0.432162548192468
CR2,Complement receptor type 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51430,0.0195637901256623,0.0129762476380367,-0.00586965524488967,0.0449972354962142,0.13164730520869
CR2,Complement receptor type 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51430,0.00942419018965198,0.0068141358440854,-0.0039315160647554,0.0227798964440594,0.166660058059244
CR2,Complement receptor type 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51430,0.00189273445884648,0.0114296523956237,-0.020509384236576,0.024294853154269,0.868473498566915
CR2,Complement receptor type 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51430,-0.00907201551426886,0.0113127891156335,-0.0312450821809105,0.0131010511523728,0.422599686732125
CR2,Complement receptor type 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51430,0.0207229106118533,0.0063684423523515,0.00824076360124435,0.0332050576224622,0.00113865788922629
CR2,Complement receptor type 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,16016,0.00961419769702456,0.0156596221460263,-0.0210786617091871,0.0403070571032362,0.539258248689099
CR2,Complement receptor type 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,16016,-0.0367949820886908,0.0134854828256096,-0.0632265284268856,-0.010363435750496,0.0063694807212002
CR2,Complement receptor type 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,16016,0.0366479594078919,0.0186114530735755,0.000169511383683867,0.0731264074320999,0.0489579280609772
CR2,Complement receptor type 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,16016,0.0462920130349639,0.0148385729412045,0.017208410070203,0.0753756159997247,0.00181352084145539
CR2,Complement receptor type 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51377,-0.0205017576955599,0.0193468379272768,-0.0584215600330224,0.0174180446419026,0.289288119601311
CR2,Complement receptor type 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51377,-0.0091188894092773,0.0287060680646927,-0.0653827828160749,0.0471450039975203,0.750740980686789
CR2,Complement receptor type 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51377,0.0158260417437956,0.0511917613580158,-0.0845098105179153,0.116161894005506,0.75720706476772
CR2,Complement receptor type 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51377,-0.0606689859313521,0.0493153970435404,-0.157327164136691,0.035989192273987,0.218618862268528
CR2,Complement receptor type 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51377,0.0149304257705229,0.0167707984877485,-0.0179403392654642,0.04780119080651,0.373328712586186
CR2,Complement receptor type 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51377,-0.0235175082102699,0.0223175121221298,-0.0672598319696443,0.0202248155491045,0.29199352798469
CR2,Complement receptor type 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51377,-0.00235702031465119,0.0103498740506383,-0.0226427734539022,0.0179287328245998,0.819853787590718
CR2,Complement receptor type 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16635,0.00918200985316068,0.0164471728517725,-0.0230544489363133,0.0414184686426347,0.57666561005495
CR2,Complement receptor type 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16635,-0.00762420297538527,0.0177299053499842,-0.0423748174613543,0.0271264115105838,0.667187115814041
CR2,Complement receptor type 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16635,0.0155100078952606,0.0239396879064541,-0.0314117804013894,0.0624317961919107,0.517072518935879
CR2,Complement receptor type 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16635,-0.00837605432087012,0.00846150776615217,-0.0249606095425284,0.00820850090078813,0.322236960032762
CR2,Complement receptor type 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23395,0.00967422065833131,0.00797279789760528,-0.00595246322097503,0.0253009045376377,0.224987856900047
CR2,Complement receptor type 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23395,-0.024439600586939,0.00776941544607984,-0.0396676548612555,-0.0092115463126225,0.00165944939131278
CR2,Complement receptor type 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23395,0.00342147914701715,0.00710847251152737,-0.0105111269755765,0.0173540852696108,0.630290674331631
CR2,Complement receptor type 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23396,0.0319378364377308,0.016830782302515,-0.00105049687519863,0.0649261697506603,0.057763106491568
CR2,Complement receptor type 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23396,-0.00473696874364263,0.0100923469409181,-0.0245179687478421,0.0150440312605568,0.63881495631029
CR2,Complement receptor type 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23396,0.00060230843812906,0.0136338127355262,-0.0261199645235023,0.0273245813997604,0.964763254658437
CR2,Complement receptor type 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51430,0.0112365666425637,0.0158783384312537,-0.0198849766826935,0.042358109967821,0.479155653507084
CR2,Complement receptor type 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51430,-0.00512492804988053,0.0111862614447554,-0.027050000481601,0.01680014438184,0.646850316326212
CR2,Complement receptor type 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51430,0.0265553681569415,0.0307517355066862,-0.0337180334361634,0.0868287697500464,0.387844406179744
CR2,Complement receptor type 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51430,-0.000741341783095422,0.0114400014982767,-0.0231637447197178,0.0216810611535269,0.948331427270474
CR2,Complement receptor type 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51430,0.0244678796705186,0.0130628120903276,-0.00113523202652342,0.0500709913675607,0.0610610249868739
CR2,Complement receptor type 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51430,-0.0118108317628492,0.0150572013333621,-0.0413229463762389,0.0177012828505405,0.432810492133854
CR2,Complement receptor type 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51430,0.00929742481458603,0.00494234439642493,-0.000389570202406844,0.0189844198315789,0.0599534851762421
CR2,Complement receptor type 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10027,0.0202508918727564,0.0146190473854325,-0.0084024410026913,0.0489042247482042,0.166009895438935
CR2,Complement receptor type 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10027,0.0410677115860551,0.0182301893207064,0.00533654051747058,0.0767988826546396,0.0242976778999578
CR2,Complement receptor type 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10027,-0.0119245973416698,0.0129546459332838,-0.037315703370906,0.0134665086875664,0.357339927469032
CR2,Complement receptor type 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10027,0.0122709115369978,0.0115820259412594,-0.0104298593078706,0.0349716823818662,0.289407312175367
CR2,Complement receptor type 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51664,0.00192870328704546,0.0057977580038318,-0.00943490240046487,0.0132923089745558,0.73938954817641
CR2,Complement receptor type 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51664,-0.00109572127307766,0.0166529985411032,-0.0337355984136399,0.0315441558674846,0.947539511574551
CR2,Complement receptor type 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51664,0.012176782754136,0.00541784729229208,0.00155780206124352,0.0227957634470285,0.0246102784913342
CR2,Complement receptor type 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51664,0.00245397371044504,0.00524081381745577,-0.00781802137176826,0.0127259687926583,0.639612892990992
CR2,Complement receptor type 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51664,0.0121285965196629,0.00811193015135634,-0.00377078657699549,0.0280279796163214,0.134879988487533
CR2,Complement receptor type 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51664,0.00828814195984489,0.00723472844998331,-0.0058919258021224,0.0224682097218122,0.251963885370543
CR2,Complement receptor type 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51664,0.0063878965974884,0.00563552064073078,-0.00465772385834393,0.0174335170533207,0.257007073921809
CR2,Complement receptor type 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51664,0.0325984055927835,0.0165529816005336,0.000154561655737621,0.0650422495298295,0.0489196965008063
CR2,Complement receptor type 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35761,-0.018105799794301,0.00567229872799884,-0.0292235053011787,-0.00698809428742328,0.00141428882660176
CR2,Complement receptor type 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35761,-0.0476280464386755,0.00592063856486191,-0.0592324980258048,-0.0360235948515461,8.9314273401268e-16
CR2,Complement receptor type 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35761,0.0469701909918746,0.00667416650816204,0.033888824635877,0.0600515573478722,1.99080364807764e-12
CR2,Complement receptor type 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,35762,0.00651820216724475,0.00914972114018692,-0.0114152512675216,0.0244516556020111,0.476225768600033
CR2,Complement receptor type 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,35762,0.0170075070312739,0.00598884621111506,0.00526936845748843,0.0287456456050594,0.00451582853234106
CR2,Complement receptor type 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51191,-0.00114309121470154,0.00582883288642416,-0.0125676036720929,0.0102814212426898,0.844525009509735
CR2,Complement receptor type 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51191,0.00535913694189889,0.00464209166650181,-0.00373936272444465,0.0144576366082424,0.248314565757975
CR2,Complement receptor type 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51191,0.00487873497477938,0.00514840234554441,-0.00521213362248766,0.0149696035720464,0.343326827186201
CR2,Complement receptor type 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51191,-0.0338341010539811,0.00932672370635489,-0.0521144795184366,-0.0155537225895255,0.000286289187121883
CR2,Complement receptor type 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51226,-0.0185932524764619,0.0051262606958563,-0.0286407234403403,-0.00854578151258359,0.000286945520674374
CR2,Complement receptor type 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51226,-0.0408783339137416,0.00800008647074717,-0.0565585033964061,-0.0251981644310771,3.23764721013471e-07
CR2,Complement receptor type 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51430,0.00327953178720186,0.005051065613927,-0.00662055681609506,0.0131796203904988,0.516163393586487
CR2,Complement receptor type 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51430,-0.0125256204689976,0.00597917081552065,-0.0242447952674181,-0.000806445670577159,0.0361869117853311
CR2,Complement receptor type 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51430,-0.00496277057875427,0.00903142906304471,-0.0226643715423219,0.0127388303848134,0.58266472770654
CR2,Complement receptor type 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51430,-0.0141140627567471,0.0114375400844761,-0.0365316413223204,0.00830351580882612,0.217204039176899
CR2,Complement receptor type 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51430,0.00340754301471118,0.0124370769645351,-0.0209691278357776,0.0277842138651999,0.784099073528945
CR2,Complement receptor type 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51430,-0.00271658627019526,0.014886784903715,-0.0318946846814767,0.0264615121410862,0.855204355834747
CR2,Complement receptor type 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29284,-0.00765853298404249,0.00315775724502516,-0.0138477371842918,-0.00146932878379318,0.0153014237869396
CR2,Complement receptor type 2,Physical activities,X864.Number of days or week walked 10+ minutes,50546,-0.0380459681137784,0.0157463586586519,-0.0689088310847361,-0.0071831051428208,0.0156880154621623
CR2,Complement receptor type 2,Physical activities,X874.Duration of walks,43787,-0.000442340594858874,0.00248422376174009,-0.00531141916786945,0.0044267379781517,0.858676770408886
CR2,Complement receptor type 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48864,-0.0639860305660812,0.0153280626279857,-0.0940290333169331,-0.0339430278152293,2.9924083859223e-05
CR2,Complement receptor type 2,Physical activities,X894.Duration of moderate activity,37844,-0.0181185610349184,0.0186335286915577,-0.0546402772703715,0.0184031552005348,0.33087601793563
CR2,Complement receptor type 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10800,-0.0128904493410013,0.00530165219002216,-0.0232816876334447,-0.00249921104855784,0.0150566785245779
CR2,Complement receptor type 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48769,-0.102136548328547,0.01578170245018,-0.1330686851309,-0.0712044115261945,9.77369073438791e-11
CR2,Complement receptor type 2,Physical activities,X914.Duration of vigorous activity,27310,-0.00632550533067655,0.00309834048355194,-0.0123982526784383,-0.000252757982914745,0.0412029534234965
